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Summary                  
Streptomyces from the genus Actinomycetales are soil bacteria known to have a complex 
secondary metabolism that is extensively regulated by environmental and genetic factors. 
Consequently they produce antibiotics that are unnecessary for their growth but are used as a 
defense mechanism to dispel cohabiting microorganisms. In addition to other isoforms 
Streptomyces galilaeus ATCC 31615 (WT) produces aclacinomycin A (Acl A), whereas its 
mutant strain HO42 (MT) is an overproducer of Acl B. Acl A is an anthracycline clinically 
approved for cancer chemotherapy and used in Japan and China. A better understanding of the 
how the different isoforms of Acl are made and investigations into a possible Acl recycling 
system would allow us to use metabolic engineering for the generation of a strain that produces 
higher quantities of Acl A with a clean production profile. 
In this study, RNA-Seq data from the WT, and MT strains on the 1st (D1), 2nd (D2), 3rd (D3), 
and 4th (D4) day of their growth was used and differentially expressed genes (DEGs) were 
identified. Differential gene expression (DGE) analyses were carried out using Bioconductor 
R-packages i.e., Bowtie2, HTSeq, and edgeR embedded in Chipster. DEGs were further 
analyzed for gene ontology (GO) enrichment and mapped to Kyoto Encyclopedia of Genes and 
Genomes (KEGG) pathways.  .  
The number of significantly (P < 0.05) DEGs from the first analysis were 891 (D1), 1573 (D2), 
1638 (D3), and 1392 (D4). However, DGE analysis by comparing RNA-Seq data within the 
strain gives two sets of gene list (WT and MT). The number of DEGs from WT were 915 (D1-
D2), 810 (D2-D3), and 363 (D3-D4) and from the MT, there were 844 (D1-D2), 145 (D2-D3) 
and 170 (D3-D4). GO enrichment analysis of the DEGs between the strains showed significant 
enrichment in polysaccharide catabolic process, carbohydrate transport, cellular process, 
organic substance metabolic and biosynthetic process, catalytic activity, hydrolase, and 
oxidoreductase activity. Additionally, these DEGs were enriched from membrane origin.  
KEGG pathway analysis of the DEGs from both data sets showed that mutant strain had a 
lower number of mapped DEGs in carbon and fatty acid metabolism, metabolism of different 
amino acids. There were variations in some primary metabolic cycles, such as the TCA cycle, 
oxidative phosphorylation, glycolysis. ABC transporter, two-component system, nucleotide 
metabolism was also varied between the strain.   
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1. Literature reviews  
1.1 Introduction  
Streptomyces are Gram-positive, mycelial, filamentous, soil-dwelling bacteria belonging to the 
genus Actinomyces whose genetic material (i.e. DNA) is GC-rich (70%)  (de Lima et al., 2012) 
that is best known for producing a diverse class of biologically active compounds (Barka et al., 
2016). The morphological differentiation process of Streptomyces is unique among the Gram-
positives such that after forming hyphae they differentiate into chain of spores and that require 
specialized and coordinated metabolism (de Lima et al., 2012). They produce secondary 
metabolites (SMs) to get a competitive advantage over surrounding species (Netzker et al., 
2018) even within the same genus (Bosso et al., 2010). Production of these SMs typically starts 
during the early stationary phase  (Nieselt et al., 2010). They are capable of producing a wide 
array of bioactive secondary metabolites (SM) such as antifungals, antivirals, antitumoral, anti-
hypertensives, antibiotics and immunosuppressives (Omura et al., 2001a).   
SMs produced by Streptomyces are not required for cell growth and reproduction, and their 
primary purpose is to improve the survivability of Streptomyces (Scherlach et al., 2013). Many 
of these SMs are further developed to medically useful products such as antibiotic drugs, anti-
cancer agents, antifungal compounds, anthelmintic drugs, and many more (Medema et al., 
2014). Among all the naturally derived antibiotics which are in use, two-third of them are 
derived from Streptomyces (Barka et al., 2016). Apart from the fact of the stress response and 
defense mechanism, antibiotics can be produced as a result of the symbiosis between 
Streptomyces sp. and a host such as insects, marine animals and plants. Streptomyces sp. exert 
antibiotics as a result of this symbiotic relationships that protect the host and host provide the 
nutrients of Streptomyces sp. Streptomyces can also develop a parasitic relationship with the 
host e.g. plant and human, and create pathogenicity in the host (Seipke et al., 2012). These SMs 
are usually encoded by a group of genes that cluster together and referred as biosynthetic gene 
cluster (BGC) (Tran et al., 2019). 
1.2 Structure and regulation of BGCs  
BGCs located in a particular area of a genome and together they encode a specific biosynthetic 
pathway for the production of specific metabolites and their variants (Kjærbølling et al., 2019 
and Osbourn, 2010). In addition to the pathway-specific regulatory genes, a BGC encodes all 
enzymes required for SM synthesis. They typically contain one or more enzyme encoding 
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genes, that synthesize the core structure of the compound, genes encode tailoring enzymes 
which are involved in modifying the core structure. Additionally, there are  enzymes those have 
regulatory functions such as transcription factors and resistance genes (Osbourn, 2010). 
Pathway-specific regulators residing within the BGC can act as activators or repressors (Van 
Der Heul et al., 2018). By responding to diverse signals, the distantly localized global 
regulators control the expression of secondary metabolism. These regulators are pleiotropic. 
Therefore, they can control the expression of several BGCs simultaneously. Events of nutrient 
starvation, chemical stressors, environmental stressors, and physical damage are the 
stimulating factors for the expression of these regulatory genes (Bibb & Hesketh, 2009). 
Besides these core biosynthetic enzymes, many BGCs also accommodate enzymes to 
synthesize modified carbohydrates (e.g. deoxy sugars in the erythromycin gene cluster) that 
are appended to the core SM structures (Oliynyk et al., 2007). Polyketide synthases (PKSs) 
and non-ribosomal peptide synthetases (NRPSs) are the most common backbone synthesizing 
enzymes (Kjærbølling et al., 2019). Beside these there are some other notable types of BGCs 
such as post-translationally modified peptides (RiPPs) (Arnison et al., 2013), terpenes, 
saccharides, alkaloids (Blin et al., 2019). The size of BGCs dramatically varies on the 
complexity of the synthesized metabolites (Baral et al., 2018). However, there might be other 
types of BGCs that are still unknown and have potentiality for SM production.  
1.3 Biosynthesis of polyketides in Streptomyces 
A large group of SMs made from polyketides, encompassing molecules such as macrolides, 
aromatics and polyenes (Cummings et al., 2014). These SMs possess a wide variety of 
structures and functions. Some of the notable functions are antibacterial (e.g. streptomycin), 
antifungal (e.g. amphotericin B), anti-cancer (aclacinomycin A), immune-suppressing (e.g. 
rapamycin), anti-inflammatory (e.g. flavonoids) (Risdian et al., 2019; Rokem et al., 2007 and 
Schwecke et al., 1995) and antiviral (e.g. antimycin A1a) (Raveh et al., 2013). Polyketide 
biosynthesis is well studied in Streptomyces (Risdian et al., 2019) and species from this genus 
produce three distinct types of polyketides (type I, type II, and type III) (Staunton & Weissman, 
2001). Biosynthesis of polyketides is a complicated process that involves multiple enzymatic 





1.3.1 Type I PKS 
Type I PKSs are multifunctional proteins that are organized into modules made up of semi-
repetitive domains, each of which executes a particular enzymatic reaction (Risdian et al., 
2019). This type of PKS is also called a modular PKS (Shen, 2003). The essential domains 
present in the modules are acyltransferase (AT), ketosynthase (KS), and acyl carrier protein 
(ACP) (Table 1.1). Each module performs a set of distinct activities responsible for the 
catalysis of  polyketide chain elongation cycle in a non-iterative way (Risdian et al., 2019). 
Table 1. 1: Some notable enzymes involve in Type I PKS synthesis and their functions. 
Enzyme Function 
Acyltransferase (AT) Acts upon acyl group and catalyze the 
binding of the substrate (e.g. acetyl or 
malonyl-CoA) to the acyl carrier protein 
(ACP) 
Ketosynthase (KS) Catalyze the condensation of ACP bound 
substrate 
Ketoreductase (KR) Reduce keto ester in the substrate 
Dehydratase (DH) Dehydrate the compound 
Enoylreductase (ER) Reduces the number of >C=C< in the 
molecule. 
 
The essential domains collaborate to produce β-keto ester intermediates (Staunton & Weissman 
2001). These keto groups are modified by other enzymes such as β-ketoreductase (KR), 
dehydratase (DH), and enoyl reductase (ER) (Figure 1.1). Before separating from the final 
polyketide product from the completed module by a specific enzyme, the growing polyketide 
chain is transferred from one module to another (Risdian et al., 2019). Type I PKSs are 





Figure 1. 1: Typical structure of a type I PKS (erythromycin A). It has 4 modules and 19 
domains. ACP, acyl carrier protein; AT, acyltransferase; KS, ketosynthase; KR, ketoreductase; 
DH, dehydratase; ER, enoylreductase (Shen, 2003). 
 
1.3.2 Type II PKS 
Type II PKSs are responsible for the synthesis of aromatic polyketides. They are classified into 
seven groups i.e., anthracyclines, angucyclines, aureolic acids, tetracyclines, tetracenomycins, 
pradimicins and benzoisochromanequinones; based on their polyphenolic ring system and 
biosynthetic pathways (Risdian et al., 2019). Amino sugar linked  tetracyclic aglycone forms 
the basic structure of anthracyclines (Beretta & Zunino, 2007). Angucyclines feature a 
tetracyclic benz[α]anthracene skeleton and forms the largest group of aromatic PKSs 
(Matulova et al., 2019).  Members of the aureolic acid family are tricyclic polyketides. 
Tetracyclines have a linearly oriented tetracyclic ring system without quinone–hydroquinone 
groups in rings B and C, but tetracenomycins have a similer ring system with quinone group in 
ring B. Pradimicins are considered as modified angucyclines. Benzoisochromanequinones 




















Figure 1. 2: Different groups of type II aromatic polyketide compounds. Aclacinomycin 
(anthracycline), jadomycin B (angucycline), mithramycin A (aureolic acid), oxytetracycline 




Type II PKSs have a cascade of monofunctional proteins, and they work iteratively unlike type 
I PKSs (Risdian et al., 2019). The synthesis of type II PKS starts from acetate or less commonly 
propionate.  At first, a liner polyketide chain consist of 16-26 carbon is assembled by repeated 
Claisen condensation reactions from a starter unit and 2-carbon acetate extender unit (Ridley 
et al., 2008). These reactions carried out by minimal PKS (minPKS) complex system, which 
comprises ACP and two KS unites (KSα and KSβ). The minPKS cooperatively produces the 
poly-β-keto chain. The α unit of the KS catalyzes the condensation of the precursor molecule, 
and the β unit in type II PKS system acts as a length determining factor. The poly-β-keto chain 
is converted to an aromatic compound by some additional enzymes e.g. KR, cyclase and 
aromatase. Afterwards, the system employs other enzymes i.e., oxygenases and glycosyl and 
methyl transferase (GT and MET) for post tailoring processes (Hertweck et al., 2007, Tang et 
al., 2017 and Staunton et al., 2001). A general illustration of Type II PKS synthesis is presented 
in Figure 1.3. 
 
Figure 1. 3: Schematic representation of the steps and reactions occurring in elloramycin 
synthesis. A Type II PKSs encoded by a typical polyketide BGC (Ogasawara et al., 2015). The 
key steps involve here are priming of the minimal PKS, formation of poly-β-keto intermediate 
from the polyketide chain by ACP and ketosynthase α/β heterodimer, followed by cyclization 
and aromatization to form the cyclized core structure by the tailoring enzymes. The 




1.3.3 Type III PKS 
Type III PKSs do not utilize ACP and they are comparatively simpler than  the other two types 
of PKS systems (Risdian et al., 2019) and can produce a wide array of compounds such as 
chalcones, pyrones, acridones, phloroglucinols, stilbenes, and resorcinolic lipids (Yu et al., 
2012). This system utilizes acyl-CoA as a substrate (Shen, 2003) and can be found in plants, 
bacteria, and fungus (Yu et al., 2012). 
 
1.4 Acl biosynthesis 
1.4.1 Structural variations of acl  
Acl are anthracycline antibiotics, produced as a complex by Streptomyces galilaeus (Oki et al., 
1975) with Acl A, B, and Y forms reported. In addition, Fujii & Ebizuka (1997) reported that 
S. galilaeus could produce Acl X. Acl A is used to treat leukemias and non-Hodgkin’s 
lymphomas in Japan and China (Räty et al., 2002). Aklavinone (Akn) (Figure 1.4a) is a 
common precursor for many anthracyclines such as daunorubicins, rhodomycins (Ylihonko et 
al., 1994) and ε-rhodomycinone (Chung et al., 2002). This molecule (Akn) forms the aglycone 
skeleton of all Acl variants. The sugar components of different Acl are rhodosamine, 2-
deoxyfucose, cinerulose A, L-aculose, and cinerulose B. Among these sugar molecules, the 
first two are common in the Acl variants (Oki et al., 1979) (Figure 1.4b). Nippon Roche group 
of Japan isolated S. galilaeus ATCC 31615 (WT), which is capable of producing Acl A and 
Acl B (Fujii et al., 1997). Random mutagenization of WT has produced several mutant strains 
for the purpose of overproducing Acl A (Figure 1.5). A key issue in the industrial 
manufacturing of Acl A is the production of a mixture of different aclacinomycins, which are 












Variant specific third sugar molecule 
 (iii)  (iv)  (v) 
(b) 
Figure 1. 4: Acl precursor molecules and its isoform specific sugar molecules. (a) Chemical 
structure of Aklavinone (Akn). Suger molecules bind to C7 of this aglycone and form different 
variants of Acl. (b) Chemical structure of the suger components present in Acl variants. (i) and 
(ii) first two common sugar molecules in Acl isoforms and (iii-v)isoform specific third sugar 





Figure 1. 5: The pedigree of mutant strains from WT. Each of the mutant strains has a 
characteristic production profile. HO42 is an overproducer of Acl B (Ylihonko et al., 1994). 
 
1.4.2 Acl recycling system 
Anthracyclines are a type II polyketide produced, especially by Streptomyces species. The 
structure of anthracycline antibiotics is divided into two parts i.e., aglycone carbon skeleton 
and sugar moiety (Ylihonko et al., 1994). Akn biosynthetic pathway starts by the condensation 
of a propionate and nine acetate molecules by a series of catalytic reactions of the minimal 
PKS, which result in a decaketide. A more stable aklanonic acid is formed after subsequent 
ketoreduction, cyclization, and oxygenation reactions of the initially formed decaketide  (Räty 
et al., 2002). Different post-polyketide reactions, such as methylation, cyclization, and 
reduction, results in the formation of the principle intermediate (Akn).   
An interesting target to study on Acl biosynthesis could be their trisaccharide moiety. The 
principal intermediate (Akn) is glycosylated; therefore, a chain of three sugar molecule 
attached with this intermediate and form Acl N. This sugar chain attached to position C7 of 
Akn as follows:  rhodosamine (Rhn)-2-deoxyfucose (dF)- rhodinose (Rho) (Räty et al., 2002). 
Rho is further converted to cinerulose by extracellular oxidoreductase (AknOx) and form Acl 
A. Furthermore, this cinerulose is converted to aculose to form Acl Y by the same enzyme 
(Alexeev et al., 2007). The final variant Acl B is formed by a non-enzymatic oxidation reaction, 








Figure 1. 7: Chemical structure of Acl A and B. They differ in the bond between the second 
and third sugar molecules (Oki et al., 1975). 
 
However, the WT strain appears to be able to harvest Acl B by transporting the molecule back 
inside the cell and re-convert it to Acl A. The mechanisms of this Acl recycling system are still 
unknown. The S. galilaeus ATCC 31615 mutant HO42 (MT) accumulates Acl B and may have 
an impaired recycling system. Genome sequencing revealed that the strain does not have any 
mutations inside the predicted BGC, which depicts the fact that this recycling system is 
partially dependent on one or more genes outside the cluster system (Figure 1.8).  
 
 
Figure 1. 8: Hypothesized recycling of Acl. (Empirically deduced by Docent Jarmo Niemi from 
University of Turku). 
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1.4.3 Characterized genes in Acl gene cluster 
The MIBiG (Minimum Information about a Biosynthetic Gene Cluster) Data Standard and 
Repository was established in 2015 to enable curation and storage of known BGCs, and during 
the last five years, 851 new BGCs have been added (Kautsar et al., 2020). Among these stored 
BGCs, this repository has information about three different publications (accession no: 
BGC0000191, BGC0000191, and BGC0000193) on Acl producing gene cluster. According to 
this repository, the BGC information for Acl biosynthesis is not complete. All the genes have 
not been characterized yet. However, researchers have characterized some of the genes from 
several experiments (Räty et al., 2000, Räty et al., 2002 and Chung et al., 2002).  
Bioinformatic analysis reveals that similar to all type II PKS BGCs, expression of the KSα and 
KSβ ketosynthase genes aknB and aknC, respectively, is translationally coupled.  Adjacent to 
them, the aknD gene closely resides (103 bp) with aknC and encodes a 91 amino acid long 
ACP. Another gene in the minimal PKS system is aknE2, which encodes a 368 amino acid 
long peptide, responsible for serving propionate as a starter unit. The genes aknD and aknE2 
are thought to be translationally coupled, and they are 4 bp overlapped. The gene aknF encodes 
a 347 amino acid peptide, which is an AT (Räty et al., 2002) (figure 1.9).  
After formation of the polyketide chain, AknA reduces the keto group at C2 to the -OH group, 
which is subsequently removed during closing and aromatization of the first ring by AknE1 
(450 amino acid peptide). The aknE1 gene is much longer than other homolog genes found in 
other type II PKS clusters. The aknX gene is assumed to be involved in oxygen addition at C12 
to make aklanonic acid at step 2 (Figure 1.6). The probable function of the gene product of 
AknV in this cluster is the glycosylation of Acl. AknG and AknH are post-polyketide enzymes. 
The 286 amino acid AknG is a methyltransferase (MET) and esterify the -COOH of aklanonic 
acid. AknH encodes a 144 amino acid peptide, which is a cyclase that closes the fourth ring of 




Figure 1. 9: Hypothesized biosynthesis of Acl sugar molecules. Extracted from Räty et al., 
(2000) and modified according to Metsä-Ketelä et al., (2007).   
 
A 280 amino acid long peptide AknI has a regulatory function that belongs to Streptomyces 
antibiotic regulatory proteins (SARPs). It acts as a pathway specific activator to promote the 
expression of genes in BGCs. The product (440 amino acid) of the aknK gene has glycosyl 
transferase (GT) activity (Räty et al., 2002) and involved in the biosynthesis of the trisaccharide 
moiety. The AknK catalyzes the transfer of a sugar molecule to the mono-glycosylated 
aclacinomycin T and converts to Acl S (Figure 1.6) (Lu et al., 2005). The cluster has another 
glycosyl transferase AknS (Räty et al., 2000 and Lu et al., 2005). AknL is thought to convert 
the dTDP-4-keto-6-deoxy-D-glucose to dTDP-4-keto-L-rhamnose (Räty et al., 2002). AknM 
is responsible for the stereospecific reduction of C4 using NADPH as a reducing agent (Räty 
et al., 2000). The pathway for dTDP-L-rhodosamine formation involves the transaminase 
encoding gene aknZ. Finally, the demethylation of dTDP-L-rhodosamine carried out by aknX2 
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gene (aknX in figure 1.9) (Räty et al., 2000 and Metsä-Ketelä et al., 2007). The cluster contains 
a large protein ( >661 amino acid) coding gene ankN, which doesn’t show significant homology 
with other proteins with known functions. Next to this gene, there is another regulatory protein-
encoding gene aknO. On the complementary strand of aknO, there is aknP which encodes a 3-
dehydratase. There is a 3-ketoreductase encoding gene aknQ on the reverse direction. AknR is 
assumed to be dTDP-glucose-4,6-dehydratase based on homology with other enzymes. The 
aknS encodes a GT and shares 13 bp overlapping sequence with aknR (Räty et al., 2000). AknS 
has deficient activity in the absence of AknT, which means AknT is an activation protein for 
AknS. It stimulates the transfer of L-2-deoxyfucose to the aglycone aklavinone (Lu et al., 
2005). The gene aknU resides in the same orientation as aknT, which encode aklaviketone 
reductase. The 259 amino acid long peptide AknW is presumably a cyclase that closes the 
aromatic ring of the aklavinone. Evidence suggested that aknY may encode  glucose-1-
phosphate thymidylytransferase (Räty et al., 2000). Experiment from Alexeev et al., (2007) 
showed that AknOx (Acl oxydoreductase) catalyzes two consecutive steps of this pathway. It 
oxidizes terminal sugar rhodinose to cinerulose A by oxidizing the -OH group at C4 to a keto 
group. In the next step, it culminates two hydrogen atoms from cinerulose A and converts it to 
L-aculose.  The characterized genes of Acl BGC has listed in Table 1.2. 
 
Table 1. 2: Deduced functions of Akn genes from Acl BGC based on homology.  
Gene product Length 
(amino acids) 
Probable function Reference 
AknA 261 Polyketide ketoreductase (KR) (Räty et al., 2002) 
AknB 423 KS I 
AknC 407 KS II 
AknD 91 ACP 
AknE1 450 Aromatase 
AknE2 368 Starter unit determinant 
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AknF 347 AT 
AknG 286 Methyltransferase (MET) 
AknH  144 Cyclase 
AknI 280 Activator 
AknK 440 GT 
AknL 201 Epimerase 
AknM >205 KR 
AknX 122 Monooxygenase 
AknN >661 Unknown (Räty et al., 2000) 
AknO 272 Activator 
AknP 434 dTDP-hexose-3-dehydratase 
AknQ 329 dTDP-hexose-3-ketoreductase 
AknR 323 dTDP-hexose 4,6-dehydratase 
AknS 443 GT 
AknU 267 Aklaviketone reductase 
AknV 144 Glycosylation  
AknW 259 Cyclase 
AknX2 238 Aminomethylase 
AknY 291 dTDP-glucose 1-synthase 
AknZ >340 Aminotransferase 
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AknOx 545 Aclacinomycin oxydoreductase (Alexeev et al., 2007) 
AknT 443 Activating protein of AknS (Lu et al., 2005) 
 
1.5 DEG analysis in prokaryotes 
A gene is defined as differentially expressed (DE) if the abundance of its transcript level is 
different per cell under the two conditions (Li & Li, 2018). High-throughput transcriptome 
sequencing (RNA-Seq) has become the key method to study DEGs (Costa-Silva et al., 2017). 
The DEGs between the treatment groups have been identified by software packages that have 
been developed based on RNA-Seq data (Zhang et al., 2014). The whole process can be divided 
into two categories: biochemistry and bioinformatics, where the generation of RNA-Seq data 
in a high-throughput platform is the biochemistry part. The generated RNA-Seq data is now 
analyzed by using various bioinformatic tools, which is a bioinformatic part of the RNA-Seq 
experiment.  
 
1.5.1 Biochemistry of RNA-Seq 
The biochemistry of RNA-Seq pipeline commonly involves three steps, such as RNA 
extraction and processing of RNA material, cDNA library preparation, and sequencing in a 
next-generation sequencing (NGS) platform. Initially, the extracted RNA materials are 
fragmented, and small complementary DNA (cDNA) sequences (reads) are generated from 
these fragments (Stark et al., 2019). Ribosomal RNA (rRNA) comprises >80% of the total 
RNA material in bacteria. However, getting a meaningful information from the RNA-Seq data, 
it is important to get the reads predominantly from the mRNA (Culviner et al., 2020; 
Westermann et al., 2012). Based on the objectives and protocols, depletion of rRNA and 
enrichment of mRNA is common for prokaryotic RNA-Seq. The fragmentation method is a 
crucial aspect of sequencing library construction. Later these cDNAs are sequenced using a 
high-throughput platform. Based on the objectives, these reads can be sequenced from one 
direction (single-end), both directions (paired-end) or a specific strand. However, single-end 
sequencing is quicker, cheaper over paired-end reads, and enough for gene expression analysis. 
PCR amplification of the cDNA would be necessary before sequencing to enrich for fragments 
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that contain the expected 5ʹ and 3ʹ adapter sequences; although this enrichment of fragments 
may cause bias in the results (Christodoulou et al., 2011).  
The word “transcriptomics” was first used in the ’90s (Nelson, 2001), and serial analysis of 
gene expression (SAGE) is the first sequencing-based transcriptomic method, which was based 
on the Sanger sequencing platform (Velculescu et al., 1995). Microarray, a dominant technique 
developed in the ’90s, was used to measure the abundance of a set of transcripts (Nelson, 2001). 
Although it was very popular at that time, this technique had notable limitations. This was a 
hybridization-based method, where user-defined probes were attached to plates for 
hybridization with sample RNA. Therefore, users could only measure defined sets of 
transcripts, which makes the experiments costly. However, the emergence of next-generation 
sequencing (NGS) technology in the 2000s (Cloonan et al., 2008) allowed researchers to 
overcome the limitations of microarrays through the development of RNA-Seq. It has been 
nearly ten years since RNA-Seq technology emerged and become a ubiquitous tool for DGE 
studies for molecular research at the transcriptomic level. The principle of RNA-Seq has not 
changed substantially since then; however, each step of RNA-Seq has gone through rigorous 
improvement (Stark et al., 2019).  Selecting a proper NGS platform is always essential and 
depends upon many factors such as experimental design, read length, and cost. The majority 
of this high throughput sequencing technology uses sequencing by synthesis method, which 
can generate tens of millions of sequences in parallel. Sequencing in the NGS platform can 
either done by sequencing many identical copies of DNA molecule (ensemble-based) or a 
single DNA molecule (single molecule-based) (Kukurba & Montgomery, 2015) e.g. PacBio 
enable single-molecule real-time (SMRT) sequencing (Eid et al., 2009). Illumina is currently 
dominating the sequencing industry, uses an ensemble-based approach (Bentley et al., 2008). 
The adaptor-ligated DNA molecules are immobilized and clonally amplified on a glass flow 
cell using fluorescently labeled reversible terminator nucleotides. The PCR amplification bias 
is removed during downstream computational analysis. This approach has much less than a 1% 





Figure 1. 10: Principle of Illumina Sequencing (Sequencing by Synthesis). (a) a simplified view 
of a flow cell; (b) fluorescently labeled nucleotides binds with the complementary bases, and a 
specialized camera captures the released fluorescent band. (c)incorporated bases in each 
cycle. d) different nucleotides with their specific fluorescents color (TUFTS, 2019). 
 
1.5.2 Bioinformatics of RNA-Seq 
From generating the data, the pipeline enters the bioinformatics part, which is also a multi-step 
process (Figure 1.11). Data analysis requires a combination of bioinformatics software tools 
based on experimental design and goals. RNA-Seq usually produces a large volume of raw 
sequence reads.   
The initial raw RNA-Seq data goes through quality control step to check multiple properties of 
these reads e.g. read length, GC content and contamination, by using one or more tools such as 
FastQC (Andrews, 2010 and Zhao et al., 2016). The small general sequences (reads) that are 
passed through the QC filter are mapped to a reference genome or transcriptome, to link 
millions of short reads into the quantification of expression.  
Mapping can be defined as aligning a short read to a specific position in the reference genome, 
where an identical sequence exists (Zhao et al., 2016). However, these short reads tend to be 
aligned with multiple locations of the genome, which makes RNA-Seq data analysis 
challenging and despite tremendous progress in RNA-Seq technologies; alignment of the reads 
is still considered as the most computationally intensive step of the entire bioinformatics RNA-




Figure 1. 11: General workflow of a typical DE analysis of RNA-Seq data. Image curtesy: 
Zhang et al., 2014. 
De novo assembly can be used to align reads to one another to construct full-length transcript 
sequences without the use of a reference genome (Hölzer & Marz, 2019). There are some 
challenges in de novo alignment, such as it requires more significant computational 
requirements than reference-based DEGs analysis, additional validation, sequencing depth and 
annotation of aligned transcripts (Oshlack et al., 2010).  
Several file formats exist to store information about the location of transcription start sites, 
exons-introns (eukaryotes) etc. They differ in several aspects; however, all the formats agree 
on having one line per genomic feature. The General Feature Format (GFF) has nine required 
fields. There are two versions of the GFF (e.g. GFF2 and GFF3) format in use, which are 
similar. GTF (Gene Transfer File) is tab limited text file, like GFF2 format, but differs in its 
9th field i.e. TYPE VALUE pairs of GTF files are separated by one space and must end with a 
semi-colon (Dündar et al., 2015). It is also possible to visualize the aligned reads against the 
reference genome by using some genomic viewer e.g. Artemis (Carver et al., 2012). 
Quantification of sequence alignments may be performed either at the gene or transcript level 
(Dündar et al., 2015).  In gene-level quantification, one can directly count the reads overlapping 
the gene loci in the genome or aggregating the transcript level quantification per gene. The 
principle of counting reads aligning to genomic features is quite simple; however, there are 
some considerations needed to take care of depending upon the experiment and desired result 
(Figure 10). HTSeq is one of the most popular tools for gene quantification (Anders et al., 
2015). It has three read overlapping counting systems, i.e., union, intersection_strict, and 
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intersection_nonempty (Figure 1.12), where union is the recommended setting. It is essential 
to know how a program is sensitive to different features, such as overlapping, reads mapped to 
more than one location, and reads overlapping multiple genomic features of the same kind, 
while choosing a program. The output summary file gives the overall statistics of the mapped 
and unmapped reads, which is very useful (Anders et al., 2015 and Dündar et al., 2015). 
 
 
Figure 1. 12: Three different modes of read counting system in HTSeq package. Based on 
certain alignment conditions (left panel) the system decides how to address the read. For 
example, in the second case, the read was partially overlapped from the annotated region of 
gene_A. In “union” and “intersection_empty” mode of read overlapping, the read belongs to 
gene_A, but in “intersection_strict” mode, the read is not counted for a gene. (Image courtesy: 
Dündar et al., 2015) 
The number of mapped reads to a gene depends upon multiple factors such as gene expression 
level itself, and other genes within the sample, the length of the gene/transcript, sequencing 
depth. Therefore, it is necessary to adjust the RNA-Seq data before making any comparative 
study (Costa-Silva et al., 2017). RNA-Seq data normalization means the raw data are adjusted 
according to the factors that prevent direct comparison of the gene expression within (e.g. 
length and GC-content) and between (e.g. sequencing depth) the samples (Zyprych-Walczak 
et al., 2015). Optimum normalization of the RNA-Seq data is one of the most important steps 
to avoid false-positive results (Dündar et al., 2015). A number of normalization methods have 
adopted for RNA-Seq data analysis packages, for example, Median (DES) adopted in DESeq 
(Oshlack et al., 2010), Trimmed Mean of -values (TMM), Upper Quartile (UQ) have adopted 
for edgeR (Marguerat & Bähler, 2010), Quantile (EBS) employed in the EBSeq package 
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(Anders & Huber, 2010) and Fragments Per Kilobase Million (FPKM) normalization (Loraine 
et al., 2015).  
Mappers have minimal impact than DEG identification on expression analysis (Costa-Silva et 
al., 2017). Additional efforts such as replicates, avoiding bias, normalization has to be taken 
into account to optimize the statistical test to determine the DEGs from the normalized RNA-
Seq data  (Dündar et al., 2015). Some of the best performing tools are edgeR (Robinson et al., 
2009), DESeq/DESeq2 (Anders et al., 2015 and, and limma-voom (Ritchie et al., 2015). 
Although edgeR has less control over false positives than DESeq and limma-voom (Ritchie et 
al., 2015 and Zhang et al., 2014); edgeR and DESeq2 are recommended if experiments has less 
than 12 replicates to capture the maximum number of DEGs even if the change is too small 
(Schurch et al., 2015).  
 
1.6 Gene ontology (GO) enrichment and pathway mapping 
1.6.1 GO consortium (GOC) 
GOC is a significant bioinformatics project that integrates information obtained from various 
sources to develop a structured controlled vocabulary (CV) to classify gene product function 
and location i.e. annotation of gene products (Huntley et al., 2014). These annotations can be 
either experimental or computational, done by expert curators. the computationally annotated 
vocabularies constitutes >98% of the total annotations (Škunca et al., 2012). At the highest 
level, these explicitly defined and structured vocabularies describe three principle information 
such as 1) the function of the gene product (molecular functions or MF), 2) their involvement 
into any biological processes (BP) and 3) their location i.e. cellular components (CC) (Hinderer 
et al., 2019). The objective is to provide an extensive, publicly available resource of functional 
annotation of genes (Huntley et al., 2014) and the functional impact of gene expression in the 
form of gene enrichment analyses (Hinderer et al., 2019). These CV of these GO terms are 
assigned with a unique alphanumeric code (Dessimoz & Škunca, 2017). These unique codes 
are used to annotate genes and gene products in many other databases, including UniProt 
(Dimmer et al., 2012) and Ensembl (Hubbard et al., 2002 and  Huntley et al., 2014). 
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1.6.2 Gene ontology 
GO is a hierarchical network of GO terms. Each term is a node, and these nodes are connected 
by edges (parent-child relationship) and describe how each term relates to one another. A child 
node can be connected to multiple parent nodes by edges. Some of the commonly used 
relationships in GO are “is a” (is a subtype of), “part of”, “has part”, “regulates” (negatively 
and positively regulates) (Figure:1.13) (“Relations in the Gene Ontology”). GO terms provide 
general insight about the mechanism of expression changes due to differences in the condition. 
GO annotation refers to the functional annotation of genes with the respective GO terms (Zhou 
et al., 2017).  
Figure 1. 13: A simple overview of parent-child relationship in GO. (a) Mitochondrion has two 
parents, it “is_an” organelle, and it is “part_of” the cytoplasm; organelle has two children: 
mitochondrion “is_an” organelle and organelle membrane is “part_of” organelle (Image 
courtesy: “Relations in the Gene Ontology”). (b) Acyclic graph of GO, each term has defined 
relationships to at least one term. This relation can disperse across the domain e.g. 
GO:0061863 is connected to both GO:0003674 (MF) and GO:0008150 (BP) (representation 
















1.6.3 GO enrichment and DEG 
Although the list of DEGs obtained from high-throughput sequencing is useful, it is not 
conveniently or directly insightful to recognize biology. Understanding the underlying 
biological process needs a functional profile of these gene sets. Thus, researchers can use 
enrichment analysis to get an understanding of the involved biological mechanisms that are 
differentially expressed due to the experimental conditions (Subramanian et al., 2005). 
Enrichment analysis is an statistical approach that helps the researchers to determine the set of 
over and underrepresented genes by comparing the input gene sets with the reference gene set 
(Subramanian et al., 2005 and Zhou et al., 2017).  
Enrichment analysis requires input files i.e. genes under experiment and a reference list. The 
reference list is important in enrichment analysis to define the background properly. For 
example, if the gene set comes from a particular strain of microbes than reference for that strain 
will generate more meaningful results than a reference from some other organism (Zhou et al., 
2017).   
Gene enrichment is calculated by different statistical methods. Some of the popular methods 
used for this purpose are Fisher’s exact test, chi-square test, hypergeometric distribution, and 
binomial distribution (Huang et al., 2009). Except for binomial distribution, the rest of them 
are thought to be suitable for smaller population background (Khatri & Draghici, 2005). 
However, they have their limitations and weakness. Therefore, the selection of enrichment 
tools based on statistical methods will not be the best idea. Researchers should test different 
testing methods for their datasets and compare the results, which will help them make a 
biological conclusion with higher confidence (Zhou et al., 2017). 
There are several tools available such as AmiGO, OBO-Edit, and GOOSE; these are developed 
and supported by GO consortium. A large number of third-party tools such as Blast2GO  
(Conesa et al., 2005) are also available that use data provided by the GO project (Zhou et al., 
2017). Blast2GO is now part of OmicsBox (“OmicsBox | BioBam | Bioinformatics Made 
Easy,” 2019) project and seamlessly integrated as a Functional Analysis Module. It enables 
GO-based data mining on GO unannotated sequences data. This feature makes it suitable for 
the current research work since the FASTA sequences of DEGs are available. In addition to 
functional annotation it supports InterPro domains, RFAM IDs, enzyme codes (ECs), and 
KEGG maps. Graphical, and analytical tools are also present in Blast2GO for annotation 
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manipulation and datamining. A typical annotation of sequences in Blast2GO involves six 
steps: BLAST, InterPro scan, mapping, annotation, enrichment analysis and visualization. B2G 
uses BLAST (Altschul et al., 1990) to find homologs to FASTA formatted input sequences 
(Figure 1.14) (Conesa et al., 2005; GöTz et al., 2008 and Zhou et al., 2017).  
 
Figure 1. 14: Schematic workflow functional annotation by Blast2GO.  Numbered circles 
denote major application steps. (1) selected sequences look for homology either in NCBI or 
custom database, (2) GO terms are mapped, (3) sequences are annotated according to the 
parameter set by the user, (4) user-defined statistical analysis (optional) e.g. GO term 
distribution, (5) annotation, and results can be visualized by GO DAG. Progress of the analysis 
can be observed and saved in each step and exported. Image courtesy: (Conesa et al., 2005) 
 
1.7 DEG and pathway mapping 
Genes function in a cooperative manner that means a gene may be one of the many genes 
involved in a specific pathway. From a given list of genes e.g. DEG, researchers may map them 
to known pathways.  Pathway mapping of the DEGs helps to determine the biological process 
the enriched genes are involved in and, consequently, reduce the complexities and improve the 
confidence of the analysis. Pathway mapping is a good choice to understand biological 
phenomena that is hidden in a given gene/protein list (Zhou et al., 2017). The Kyoto 
Encyclopedia of Genes and Genomes (KEGG), Reactome, PANTHER, and BioCyc are some 
major metabolic pathway databases (Zhou et al., 2017). 
In KEGG database, genes are annotated with a KEGG orthology (KO) identifiers or K numbers 
that represents an orthologues group of genes and KEGG Automatic Annotation Server 
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(KASS) is a web-based service integrated to KEGG system that enables the reconstruction of 
KEGG pathways and BRITE hierarchies by assigning K numbers (based on sequence 
similarities) to the genes in the genome. At first, the query sequences (in FASTA format) are 
blasted against the reference sequence set (taken from KEGG database). The BLAST score and 
bi-directional best hit rate are computed and selected; those are above the threshold level. 
Orthologs are divided into KO groups according to the KEGG genes database. Then the KO 
groups are ranked based on the likelihood and heuristics. Finally, the K-number with the 

















2. Aims of the study 
Aims of this study are: 
a. Understand the unique Acl recycling system in S. galilaeus ATCC 31615. 






3. Materials and methods 
The research work was carried out Antibiotic Biosynthetic Engineering lab located in Biocity, 
Turku, from September 2019 – June 2020. The RNA-Seq data was generated using the facility 
of The Finnish Functional Genomics Center (FFGC) located on the same premises. The mRNA 
library was prepared from 1000 ng total RNA, and the mRNA enrichment was done using a 
MICROBExpressTM Bacterial Enrichment Kit (ThermoFisher Scientific). From the 
fragmentation step, Illumina TruSeq® Stranded mRNA Sample Preparation Guide was 
followed for the library preparation. The first cDNA strand was synthesized from the 
fragmented mRNA, using transcriptase and random primer. dTTP was replaced by dUTP for 
strand specificity and used as a quencher for second strand amplification. To further improve 
strand specificity by allowing only RNA-dependent synthesis, Actinomycin D (Act D) was 
added to the reaction mixture. The synthesized cDNA was then ligated to the unique Illumina 
TruSeq indexing adaptors according to the protocol and enriched with PCR to create the final 
cDNA library. Advanced Analytical Fragment Analyzer was used to analyze the quality of the 
libraries and quantified by Qubit® Fluorometric Quantitation Life Technologies. The RNA-Seq 
library fragments were in the range of 200-700 bp, and the average size of the fragment was 
250-350 bp were allowed for sequencing. Samples were sequenced with Illumina HiSeq3000 
instrument with read length 1 x 50 bp. The above-mentioned experimental work was performed 
as a service by the FFGC. 
All the analyses performed in the lab computer and the software used were either free or a trial 
version. Bioinformatics analysis of RNA-Seq data was divided into four categories: a) 
prediction of the Aclacinomycin encoding BGC by antiSMASH, b) detection of the DEGs, c) 
GO enrichment analysis, and d) pathway mapping of the DEGs. For DEGs identification, the 
web version of Chipster (Kallio et al., 2011) software (version 4), which accommodates various 
tools required for high-throughput data analysis, was used.  GO enrichment analysis of the 
DEGs was performed using Blast2GO version 5.2.5, which is integrated into Omicbox software 






3.1 RNA-Seq dataset 
The RNA-seq dataset used in this study was generated from WT and its mutant MT and in 
FASTQ format. Samples were taken at four-time points i.e. day 1, day 2, day 3 and day 4 from 
both strains. Data from WT was used as a control strain for the differential expression analysis.  
3.2 Detection of Acl producing BGC 
Acl encoding secondary metabolite was predicted and annotated using the web-based software 
antiSMASH 5.1.2 (Blin et al., 2019). The reference genome sequence (unpublished) was 
uploaded in antiSMASH (https://antismash.secondarymetabolites.org/#!/start). The detection 
strictness was left in "relaxed" mode, and detection of all the extra features was turned ON. It 
uses profile Hidden Markov Model (pHMM) based on multiple sequence alignments of 
experimentally characterized protein or protein domains for BGC identification (Blin et al., 
2017). After submitting the genome sequence, the server predicts different secondary 
metabolite-producing clusters throughout the genome. 
3.3 Identification of DEGs 
Data analysis begins with the input of the raw read files and the reference files. The read files 
were uploaded in the Chipster system. The read files were unzipped and extracted to FASTQ 
format and underwent a quality control step by FastQC (Andrews, 2010). Raw data delivers 
immediate insight into the sequence quality for further downstream analysis. After checking 
the  quality parameters, for example GC content which indicates any possible contamination 
in the raw data and eventually has great importance in transcript detection and abundance 
quantification, The reads from each sample were aligned with the reference genome sequence 
(WT) by the Bioconductor package Bowtie2 (Langmead & Salzberg, 2012). All the settings 
for alignment were left as default.  
This tool returns a BAM file that contains the alignment and an index file for it (.bai). It also 
produces a log file. This log file shows the result of the alignment i.e., percentage of the aligned 
(unique and non-unique) and non-aligned reads on a particular setting. 
After completing the alignment, reads that were mapped to the feature of interest were counted. 
The mapped reads in the BAM files were then counted against the genes by HTSeq (Anders et 
al., 2015). To do so, a GTF (Gene transfer format) file was provided. This tab limited text file 
contains the information about gene structure. This tool calculated how many reads were 
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mapped to the genes and makes two output; one is a tab limited file (.tsv) which contain the 
number of reads on each gene and a .txt file which mainly shows the how many reads were 
counted and not counted. Some of the parameters were changed from the default settings such 
as “Is the data stranded and how” changed to “reverse” which means the second read of a pair 
should map to the same strand of the gene, minimum alignment quality was set to 1 to increase 
the number of counted reads and the feature type was changed to CDS since  the data came 
from a prokaryotic organism.  
Before performing the DEG analysis, count files were merged  using “Define NGS experiment” 
tools. A phenodata file was also created by this tool. For DEGs between the strains, the count 
files of WT and MT from the same time points were combined, and for the analysis of DEGs 
within the strains, count files from D1-D2, D2-D3 and D3-D4 were combined. Therefore, the 
read counts were ready for pairwise comparison DEG of the two groups. The pairwise DE 
analysis allows the identification of DE genes in a pairwise comparison of two different 
experimental conditions. To perform this comparison, Bioconductor package edgeR (Robinson 
et al., 2010) was used. Here all the parameters were unchanged except the dispersion value, 
which was set to 0.01. 
The expression differences between different conditions compared with edgeR created a list of 
genes that are associated with Log2 fold change (LogFC), log- counts per million (log-CPM), 
p-values, and false discovery rate (FDR). All the parameters were set to default except the 
“dispersion value” which was set to 0.01 because the samples were pooled, and variability was 
counted. Fold change (FC) is often used to measure the change in gene expression level in gene 
expression analysis by microarray, RT-qPCR, and RNA-seq. The LogFC can be defined as the 
log ratio of the genes/transcript's expression values in two different conditions. LogFC is used 
for better scaling of fold changes. In the present study, transcripts with LogFC < −1 as down-
regulated and transcripts with LogFC > 1 were characterized as up-regulated. Counts Per 
Million (CPM) is a filter to exclude genes with low counts across libraries. Log CPM is the log 
counts per million, which is measuring relative abundance of expression normalized for library 
size ad transcript length. The False Discovery Rate (FDR) controls the number of false 
discoveries in significant discovery (i.e. a significant result) that determines adjusted p-values 
for each test. In this study, the number of DE genes was detected by using the FDR < 0.05, 
which infers less than 5% of significant tests will result in false positives. To make the analysis 
simpler, I had selected 5 DEGs up and 5 DEGs downstream from the Acl producing cluster 
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detected by antiSMASH, including the genes residing in the cluster. In addition to these genes, 
ten most up-regulated and ten most down-regulated genes on different days were analyzed. 
The results from this DE analysis was used to determine the genes regulations possibly 
associated with the Acl gene cluster. Furthermore, a tab limited files of these DEGs were sorted 
according to LogFC value and exported. A python script (provided by Keith Yamada M.Sc.) 
was used to extract the corresponding FASTA sequence of these sorted DEGs. These FASTA 
sequences later used for GO enrichment analysis and KEGG pathway mapping.  
 
3.4 GO enrichment analysis: 
The amino acid sequences in the FASTA file created from DEG analysis were sorted according 
to the log2FC value. GO enrichment analysis of these up and down-regulated genes was done 
by the functional analysis module of Omicsbox software in two steps: gene ontology annotation 
and gene ontology enrichment (Figure 2.1). Omicsbox uses Blas2GO methodology (Conesa et 
al., 2005) for this purpose by following steps. The FASTA sequences of the DEGs at different 
time points were uploaded into the module. After that NCBI QBlast service (non-redundant) 
was used to blast those sequences against protein database. BlastP algorithm was used since 
the query sequence were amino acid sequence. The taxonomic filter was set to Streptomyces to 
widen the specificity of the annotation. The purpose of this step was to find sequences similar 
to the query set. The sequences were mapped by retrieving blast hit associated GO terms. By 
applying an annotation rule ("Gene Ontology Annotation"), the GO terms were selected from 
the GO pool obtained in the mapping step. After that, the selected GO terms were assigned to 
the query sequence. InterPro annotation helps to retrieve domain/motif information of the 
amino acid sequences. The sequences were annotated with the corresponding GO terms merged 
with already existing GO terms. For InterPro annotation, EMBL-EBI InterPro web-service was 
used. The sequence annotation results were then exported as .annot format and used as 







Figure 3. 1: Gene enrichment analysis workflow of the DEGs. a) the annotation of the DEGs 
and b) gene enrichment analysis with the help of a GO annotated file. Image curtesy: 
(OmicsBox | BioBam | Bioinformatics Made Easy, 2019) 
For enrichment analysis (Fisher's Exact Test), Blast2GO employs FatiGO package (Al-
Shahrour et al., 2004). In the gene enrichment step (Figure 3.1b), the tab limited files (.tsv) 
created in the DEG analysis were uploaded, and the previously created “.annot” file was used 
as a reference set. Then the overrepresentation of the up and downregulated genes was tested 
for gene enrichment. The filter value was set to p < 0.05.  
3.5 KEGG pathway mapping of DEGs:  
The DEGs were mapped to different pathways by using KAAS. The FASTA sequences of the 
up-regulated and downregulated genes were functionally annotated by BLAST 
(https://www.genome.jp/kaas-bin/kaas_main?mode=partial) against the manually curated 
KEGG GENEs database. Streptomyces coelicolor, Streptomyces avermitilis, Streptomyces 
griseus, Streptomyces scabiei and Streptomyces noursei were selected as a template data set 
for KO assignment to find the ortholog of the corresponding amino acid sequences by single-





4.1. Analysis of the transcriptomic data 
In this study, RNA-Seq data obtained from WT and MT was compared between the strains 
(WT vs. MT) and within the strains (time points). Transcriptomic data from WT and MT were 
compared with each other obtained at the same sampling time. Measurement of DE within the 
strain came from the transcriptomic data of a strain with 1-day intervals. WT considered as a 
control group during between the strain comparison. In contrast, there was no direct control 
while comparing within the strain, but a comparative analysis has made by comparing WT vs 
MT at the same time interval i.e. D1-D2, D2-D3 and D3-D4. 
The number of raw reads obtained from each sample ranged from 13.5 to 18.3 million single 
end fragments (one read per fragment). The average number of reads from WT and MT were 
15.3 and 16.4 million, respectively. Bowtie2 aligned those reads with the WT genome at the 
rate ranges between  96.21% to 98.14%, respectively. This result indicated the consistency of 
the mapping of reads, especially with regards to the mutations in the MT (Table 4.1).  
There are 8807 annotated genes in the WT genome. The number of significantly (P < 0.05) 
DEGs from day 1 to day 4 were 891, 1573, 1638, and 1392 respectively, after comparing the 
RNA-seq data from two different strains. It corresponds to 10.11-18.59% of the total genes 
(Figure 4.1a). Later the DEGs were compared within the strain but on different days, i.e. day 1 
vs day 2, day 2 vs day 3 and day 3 vs day 4 (Figure 4.1b).  A list of 20 most up and down-






Figure 4. 1: Number of DEGs. a) compared between WT and MT and b) compared within the 
strain (in X-axis M/W denotes MT/WT and the number 1-4 denotes the days).   
It is important to note that many genes overlapped over time among the DEGs mentioned 
above.   The number of unique and overlapping genes from the different DEG pools is 
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Figure 4. 2: Venn diagram of the number of unique and overlapping genes between/among 
different analyzed time points. a) represents DEGs between the strains, b) and c) represents 
the DEGs within the strain, and d), e) and f) represents the number of shared DEG at the same 
time points of MT and WT. The area of the diagrams does not represent the number of genes. 
W: Streptomyces galilaeus ATCC 31615  and M : Streptomyces galilaeus ATCC 31615 HO42; 




Table 4. 1: Summary of the RNA-Seq reads for each sample.  WT:  Streptomyces galilaeus ATCC 31615, sample name refers to corresponding BAM file.
Strain Sample Time 
point 
(day) 





0 1 >1 
  
No. Reads % No. 
Reads 
% No. Reads %  % 
MT D1_42_1_S29_L003_R1_001.fastq D1 429421 2.74 305736 1.95 14918507 95.3 15.6 97.26 
D2_42_2_S31_L003_R1_001.fastq D2 366202 2.21 1211775 7.31 14989622 90.48 16.5 97.79 
D3_42_1_S33_L003_R1_001.fastq D3 659621 3.61 1443887 7.91 16161084 88.48 18.3 96.39 
D4_42_3_S35_L003_R1_001.fastq D4 398846 2.63 1217474 8.02 13573521 89.36 15.2 97.37 
 Average  463522.5 2.79 1044718 6.29 14910683.5 90.9 16.4 97.25 
WT D1_WT_1_S28_L003_R1_001.fastq D1 536348 3.25 837282 5.08 15118620 91.67 16.5 98.14 
D2_WT_3_S30_L003_R1_001.fastq D2 595101 3.79 1695412 10.81 13396392 85.4 15.7 96.21 
D3_WT_2_S32_L003_R1_001.fastq D3 400936 2.61 2738359 17.83 12215830 79.56 15.3 97.39 
D4_WT_3_S34_L003_R1_001.fastq D4 350805 2.59 3200015 23.67 9970901 73.74 13.5 97.41 
 Average  470797.5 3.06 2117767 14.3 12675435.8 82.5 15.3 97.28 
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4.2 Acl producing BGC prediction 
The web application antiSMASH (version 5.1.2) had predicted 31 genomic regions (Table 4.2) 
involved in secondary metabolism across the WT genome, of which eight regions show 100% 
similarity with the known BGCs. This strain is best known for aclacinomycin production, 
which corresponds to region 13 (Table 4.2). This predicted BGC consists of 71 genes from 
2133094 to 2204805 bp of the genome (Appendix 2).  
Table 4. 2: Predicted genomic regions of WT for secondary metabolites production. LAP: 
Linear azol(in)e-containing peptides, hgIE-KS: heterocyst glycolipid synthase-like PKS, T: 
type. 
Regions Type From To Most similar 
known cluster 
Similarity 
Region 1 LAP 44800 66996   
Region 2 Terpene 296516 316583   
Region 3 T1PKS, NRPS, 
Lassopeptide 
389139 443213 Citrulassin D 100% 
Region 4 T1PKS 491642 535706 Herboxidene 7% 
Region 5 Terpene 603901 628502 Isorenieratene 100% 
Region 6 Melanin 1143964 1152805 Melanin 57% 
Region 7 Bactericin 1308299 1316450 Informatipeptin 42% 
Region 8 hgIE-KS, 
T1PKS 
1586530 1637245 Miharamycin 
A/B 
11% 
Region 9 Terpene 1669117 1695582 Hopene 92% 





Region 11 Oligosaccharide 2046082 2091954 Meiingmycin 5% 
Region 12 Siderophore 2116328 2128615 Grincamycin 8% 
Region 13 T2PKS 2133094 2204805 Cinerubin B 100% 
Region 14 Terpene, 
butyrolactone 
2308100 2329493 y-butyrolactone 100% 
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Region 15 Bactericin 2358421 2369752   
Region 16 Lassepeptide 2430086 2452607 SSV-2083 36% 
Region 17 Siderophore 2613627 2525119   
Region 18 Terpene 3195093 3215132 Albaflavenone 100% 
Region 19 NRPS 5131759 5185615 Ishigamide 66% 
Region 20 Siderophore 5638454 5650259 Desferrioxamine 83% 
Region 21 Melanine 5753528 5764088 Istamycin 4% 
Region 22 NRPS 6073670 6137868 SCO-2138 71% 
Region 23 transAT-PKS, 
NRPS 
6313466 6395279 Leinamycin 12% 
Region 24 Ectoine 6871301 6881705 Ecotine 100% 
Region 25 T2PKS 7608932 7681447 Spore pigment 83% 
Region 26 NRPS, T1PKS 7889667 7955546 Foxicins A-D 14% 
Region 27 T3PKS 7980839 8022023 Germicidin 100% 
Region 28 NRPS, T1PKS 8169813 8241883 Foxicins A-D 12% 
Region 29 NRPS 8302091 8352417 Coelichelin 100% 
Region 30 Terpene 8610846 8632924   
Region 31 NRPS 8712662 8824130 Enduracidin 14% 
antiSMASH identified different regions of a BGC based on their corresponding function for 
BGC synthesis, e.g. core biosynthetic genes (CBG), additional biosynthetic genes (ABG), 
transport-related genes (TG), regulatory genes (RG) and other genes (OG) (Figure 4.3). The 
length of the genes and their functions are in appendix 2. Functional roles have been collected 
from the GenBank file of WT. Additionally, some functions had been deduced by blastP.  
 
Figure 4. 3: Predicted genes in Acl producing BGC. The color of the legends shows the function 
of the predicted genes in the BGC and their direction.  
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4.2.1 DEGs from the predicted Acl producing cluster 
The differential expression may vary since the RNA samples of three biological replicates were 
pooled together. Thus, the number of replicates for transcript analysis is one (N=1) and after 
that the significantly (P < 0.05) DEGs within and between the WT and MT were calculated. 
The comparative transcript count level within the strain revealed the significant (P < 0.05) 
DEGs between the transcriptome on different days. The level of differential expression was 
determined by the LogFC value (P < 0.05). A ‘+’ value means up-regulation, whereas a ‘-’ 
value denotes downregulation. 
4.2.1.1  DEGs within the strains 
The comparative DGE analysis (Table 4.3) demonstrated a pattern of expression, i.e., most of 
the genes were downregulated at the first interval (D1-D2) and slightly upregulated during the 
third interval (D3-D4). In general, genes from the WT were more downregulated than their MT 
counterpart. However, WT showed slightly higher upregulation than MT strain. 
4.2.1.1.1 DEGs within the WT strain 
From the 72 genes that consist of the predicted Acl BGC, the number of   significantly (P < 
0.05) DEGs were 49 during the first interval. The number of the upregulated genes was 3 and 
the rest of the 46 genes were downregulated. There were only 4 DEGs (P < 0.05) during the 
second interval.  There were only 4 significant (P < 0.05) DEGs during the second interval 
(D2-D3). Finally, there were 32 genes those are significantly (P < 0.05) differentially expressed 
during the third interval and all of them were upregulated (Table 4.3). 
4.2.1.1.2 DEGs within MT strain 
MT displayed a relatively similar pattern of differential gene expression. However, the degree 
of DE was different. There were 45 significantly (P < 0.05) DEGs during the first interval, of 
which only one was upregulated. The number of DEGs (P < 0.05) was lowered to 19 genes, 
and all of them were downregulated. However, the degree of downregulation was lower than 
the first interval and this direction of positive regulation was continued in the third interval. 
The number of DE genes that were significant is 16 (P < 0.05), and all of them were upregulated 
but their degree of upregulation was lower than WT at the same interval .  
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Table 4. 3: DEGs (P < 0.05) within the predicted Acl producing BGC of WT and MT strains 
on different days. DEs were determined within the strain. Genes without showing any LogFC 
value didn’t differentially expressed (P < 0.05) and aren’t shown. +/- denotes 
up/downregulation, respectively. D1, D2, D3, D4 represents the sampling day. DEGs with  -
1>LogFC>1 value was presented only. 
Gene ID LogFC 
WT MT 
















   
fig|33899.16.peg.2253 2.476 3.343 
 










































2.286 -3.241   
fig|33899.16.peg.2271 -5.388 
 
2.402 -3.626   
fig|33899.16.peg.2273 -5.035 
 
1.982 -2.800   
fig|33899.16.peg.2274 -3.700 
 








2.237 -3.193 -1.192 1.353 
fig|33899.16.peg.2277 -4.637 
 
2.248 -3.052 -1.227 1.203 
fig|33899.16.peg.2278 -4.862 
 
2.494 -3.618 -1.089 1.131 
fig|33899.16.peg.2279 -4.214 -1.190 2.217 -3.292   
fig|33899.16.peg.2280 -4.654 
 
2.060 -3.559 -1.202 1.136 
fig|33899.16.peg.2281 -5.390 
 
2.259 -3.705 -1.108 1.082 
fig|33899.16.peg.2282 -5.506 
 
2.573 -3.664 -1.113 1.243 
fig|33899.16.peg.2283 -5.493 
 
2.340 -3.181 -1.319 1.387 
fig|33899.16.peg.2284 -5.058 
 
2.504 -3.545 -1.260 1.081 
fig|33899.16.peg.2285 -4.775 
 
2.177 -3.243 -1.217 1.339 
fig|33899.16.peg.2286 -4.364 
 
2.238 -2.648 -1.233 1.078 
fig|33899.16.peg.2287 -4.853 
 
2.493 -3.252 -1.259 1.413 
fig|33899.16.peg.2288 -4.272 
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fig|33899.16.peg.2314 -1.999 
     
 
4.2.1.2 DEG of the predicted Acl producing BGC between WT and MT 
The same transcriptomic data mentioned above was also analyzed to observe the differential 
gene expression between the strains. During the growth period, of the 72 genes that are 
involved in the predicted BGC, 40 (D1), 41 (D2), 41 (D3), and 37 (D4) genes were 
differentially expressed. The percentages of the DEGs against the number of predicted genes 
in the BGC for Acl synthesis were between 31.94 % to 52.77% . However most of the DEGs 
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were upregulated and the percentages of upregulated genes on different sampling days were 
93.33% (D1),  91.89% (D2) 89.20% (D3), and 77.30% (D4) (Table 4.4). 
 
Table 4. 4: DEGs (P<0.05) within the predicted Acl producing BGC of WT and MT strains on 
different days. Differential expression was determined between the strains from their 
transcriptomic data obtained on the same days. Genes without showing any LogFC value were 
not differentially expressed (P<0.05) and aren’t mentioned. +/- denotes up/down-regulation, 
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fig|33899.16.peg.2265 1.803 1.363 1.467 
 
fig|33899.16.peg.2266 1.219 2.423 2.264 0.807 
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fig|33899.16.peg.2267 1.334 2.348 1.919 1.084 








2.957 2.145 1.072 
fig|33899.16.peg.2274 1.093 2.135 1.772  
fig|33899.16.peg.2275 1.221 2.548 1.930 
 
fig|33899.16.peg.2276 1.252 2.577 2.312 1.442 
fig|33899.16.peg.2277 1.125 2.626 1.939  
fig|33899.16.peg.2278 1.543 2.703 2.305  
fig|33899.16.peg.2279 1.427 2.266 2.621 1.337 
fig|33899.16.peg.2280 1.524 2.535 2.062 1.151 
fig|33899.16.peg.2281 1.511 3.112 2.299 1.135 
fig|33899.16.peg.2282 1.191 2.949 2.410 1.093 
fig|33899.16.peg.2283 
 
3.207 1.888  
fig|33899.16.peg.2284 1.414 2.844 2.465 1.055 





fig|33899.16.peg.2287 1.633 3.150 2.235 1.168 
fig|33899.16.peg.2288 
 
2.365 2.346 1.326 
fig|33899.16.peg.2289 1.074 2.451 2.178 1.073 
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fig|33899.16.peg.2290 1.850 2.118 1.873 1.018 
fig|33899.16.peg.2291 1.182 2.455 2.054 
 
fig|33899.16.peg.2292 1.050 2.271 1.865 
 
fig|33899.16.peg.2293 1.065 2.855 2.016 
 






fig|33899.16.peg.2297 1.337 2.381 1.898 1.274 
fig|33899.16.peg.2298 
 
2.289 1.941 1.299 





fig|33899.16.peg.2303 1.746 2.306 1.911 1.896 
 
4.3 Functional annotation and GO enrichment analysis 
4.3.1 Functional annotation based on GO 
DEGs involved in MF, BP, and CC were identified by GO analysis. The DEGs from the 
between strain comparison was GO annotated and submitted to WEGO for classification. The 
number of GO annotated DEGs were 651 (73.06%) on day 1, 1132 (71.96%) on day 2, 1178 
(71.92%) on day 3 and 989 (71.05%) on day 4 (Figure 4.4).  
These GO annotated DEGs were classified into 36 GO categories at GO level 2. The 
distribution of the functional terms was as follows: 19 terms for BP, 9 terms for CC, and 8 
terms for MF. In the CC category, cell, cell part, membrane, and membrane categories were 
the top four regarding the number of DEGs. In the MF category, the DEGs were primarily 
involved in catalytic activity and binding. Finally, metabolic process, cellular process, 
localization were the top two terms in the BP category, from day 1 to day 4 (Figure 4.5). The 
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GO terms mentioned above were at level 2.  According to the frequency of a GO term, the top 
30 most specifically annotated GO terms and their corresponding DEG numbers were 
presented in appendix 3.  
 
  
a)  b)  
Figure 4. 4: GO annotation of the DEG between the strains. a) the number of DEGs and the 
number of GO annotated DEGs, b) the categories of annotated GO to those DEGs. One single 
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Figure 4. 5: GO categories of the DEGs between the strain comparison on different days. a) 
day 1, b)day 2, c) day 3 and d) day 4. The y-axis on the left represents the percent of the GO 
annotated DEGs that belong to a GO term, and the on the right side represents the number of 
DEGs. 
The DEGs that were successfully annotated with GO terms undergo GO enrichment analysis 
(0.05 > P) (Figure 4.6). The gene enrichment for the downregulated DEGs showed higher 
number of categories therefore categories enriched with more than 10% DEGs are mentioned 
for convenience.  
The upregulated DEGs were not enriched with any GO terms under the BP on the first two 
days. However, genes for the BP were enriched (among others) with antibiotic and drug 
metabolic process and polysaccharide catabolic process (day 3) and carbohydrate transport 
(day 4) (Figure 4.6 a). The downregulated genes were mainly enriched with the cellular process 
on days 1, 2, 3, and 4.  Metabolic and biosynthesis process such as peptide, cellular protein, 
cellular macromolecule, cellular, organic substance, primary metabolic processes were 
enriched on day 1.  Both localization, and establishment of localization were enriched on day 
3 and 4. On day three it was observed that transport was enriched and on day 4 biosynthetic 
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processes such as organic substances, cellular, biosynthetic process were enriched along with 
cellular metabolic process (Figure 4.6 d).  
The GO enrichment for MF for the upregulated genes varied every day. The first day it was 
dominated by “peptidase activity,” whereas  “oxidoreductase activity” dominated on the 
second day. On the third day, the enrichment was broadened and significantly dominated by 
“catalytic activity” over other GO terms (Figure 4.6 b). However, the downregulated DEGs 
were enriched with broader GO terms for MF. MFs such as binding, heterocyclic, and organic 
cyclic compound binding were significantly enriched (among others) on day 1 (Figure 4.6 e). 
Day 3 was mainly enriched with different binding activities e.g. ion, nucleotide, anion, small 
molecule, and nucleoside phosphate binding.  Binding activity was again enriched on day 4 
along with heterocyclic compound, organic cyclic compound binding, and transferase activity 
(Figure 4.6 e).  
GO enrichment for the CC was much less diversified than the previously mentioned categories. 
The CC of the upregulated genes identified by GO enrichment analysis included (among 
others) membrane (day 1 and 4), an integral component of the membrane, and intrinsic 
component of membrane (day 4) (Figure 4.6 c), while the cellular component of the 
downregulated genes included (among others) cellular, anatomical entity (day 1), integral and 
intrinsic component of membrane (day 2), plasma membrane and cell periphery (day 3 and 4) 
(Figure 4.6 f).    
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Figure 4. 6: GO enrichment (0.05>P-value) of the DEGs (between the strains) on different 
days. Gene enrichment from the upregulated genes involved in a)BP, b)MF and c) CC. Gene 
enrichment from the downregulated genes involved in d)BP, e)MF and f) CC. X-axis represents 
% of the DEG sequences that were enriched, and Y-axis represents GO.   
4.4 Pathway analysis of DEGs from between and within strain comparisons 
The functions of the DEGs were assigned to the KEGG pathways for a better understanding of 
their biological functions in a specific pathway. FASTA sequences contain both up and 
downregulated genes obtained from the DEG list after the comparisons between and within the 
strain were mapped to KEGG pathways together, and their role in metabolic pathways and 
biological behaviors were analyzed. The percentage of the mapped DEGs range between 
52.01% to 37.93% (Figure 4.7). The mapped genes are mainly fit into four categories i.e. 
metabolism, genetic information processing, environmental information processing, and 
cellular process. Pathways having less than 1% of the mapped DEGs were excluded. They are 
further subdivided into more sub-classes according to the annotation of the DEGs of different 
days. However, most of the genes were annotated to different metabolic pathways. The global 
and overview metabolism of mapped genes is presented in Figure 4.8.  
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Figure 4. 7: Number and percent of the DEGs those are mapped by KEGG mapper KAAS and 
their corresponding number of mapped pathways. W1, W2 , W3 and W4 refers to the 
corresponding sampling day of the WT strain, and M1, M2,M3 and M4 refers to the sampling 
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Figure 4. 8: The number of mapped DEGs to the global and overview map. (a) DEGs between 
the strains (b) DEGs within the strains. SM - secondary metabolites. W1, W2 , W3 and W4 
refers to the corresponding sampling day of the WT strain, and M1, M2,M3 and M4 refers to 
the sampling day from the mutant strain. 
4.4.1 KEGG mapping of the DEGs between the strains 
FASTA sequences of the DEGs between WT and MT obtained from four time points i.e. D1, 
D2, D3 and D4 were mapped to metabolism are categorized into 8 secondary classifications 
such as amino acid metabolism (14 pathways), carbohydrate metabolism (10 pathways), energy 
metabolism (4 pathways), metabolism of terpenoids and polyketides (3 pathways), nucleotide 
metabolism (2 pathways), glycan biosynthesis (1 pathway), metabolism of cofactors and 
vitamins (1 pathway) and lipid metabolism (1 pathway) (Figure 4.9 a, b, c). Amino acids are 
the building block of protein. The enriched pathways of the amino acid and carbohydrate 
metabolism reflected the growth cycle of the bacterial. Most of the mapped genes were either 
from day 2 or day 3 (Figure 4.9 a, b). The oxidative phosphorylation pathway under energy 
metabolism showed the highest number of mapped genes. There were 25 DEGs mapped to this 
0 20 40 60 80 100 120 140 160 180 200
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pathway on day 3. Nitrogen and sulfur metabolism pathways from this same category had the 
highest mapped DEGs on day 3 (Figure 4.9 c). Two pathways from genetic information 
processing category were enriched with the mapped DEGs. However, more than 30 genes were 
mapped to ribosomes under the translation category indicates a higher amount of activity from 
the translational machinery from day 1 and 3 (Figure 4.9 d).  The intercellular antibiotic is 
transported by proton dependent transmembrane electrochemical system. ABC (ATP binding 
cassette) transporter protein is known to energizing this transport system. This transporter 
system had the highest number of mapped genes on day 2, 3, and 4 (highest on day 3) among 
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Figure 4. 9: Functional classifications of the mapped DEGs between the WT and MT strain on 
different days. DEGs mapped to different metabolic pathways of (a) amino acid, (b) 
carbohydrate, (c) energy, glycan biosynthesis, lipid, cofactors and vitamins, terpenoids and 
polyketides and nucleotides, (d) pathways involved in cellular processing (CP), genetic 
information processing (GIP) and environmental information processing (EIP). EM- energy 
metabolism, GBM-glycan biosynthesis and metabolism, LP-lipid metabolism, MCV-
metabolism of cofactors and vitamins, MTP-metabolism ofterpenoids, and polyketides, and 
NM-nucleotide metabolism. Y-axis denotes the number of mapped DEGs into the pathway.  
4.4.2 KEGG mapping of the DEGs within the strains 
All the DEGs from the WT and MT strains from three-time intervals were mapped to different 
pathways. There were variations in their gene mapping. Physiologically critical pathways are 
in Figure 4.10, and the detailed pathway mapping result is presented in Appendix 4. 
These DEGs from the WT were mapped to metabolism are categorized into eight secondary 
classifications such as amino acid metabolism (13 pathways), carbohydrate metabolism (10 
pathways), energy metabolism (4 pathways), metabolism of terpenoids, and polyketides (4 
pathways), nucleotide metabolism (2 pathways), lipid metabolism (2 pathways), other 
secondary metabolites (1 pathway), metabolism of cofactors and vitamins (1 pathway) 
(Appendix 4 a, b, c, d).  
The number of mapped metabolic pathways related to amino acids was predominantly higher 
than other pathways. The pathways for carbohydrate metabolism were higher. Together, they 
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pathways belong to amino acid metabolism had shown a higher number of mapped DEGs on 
the first interval, i.e., W1-W2 (Appendix 4 a). All the pathways for carbohydrate metabolism 
showed a higher number of mapped DEGs at the same period (Appendix 4 b).  
The number of DEGs mapped in oxidative phosphorylation was highest at the second interval, 
i.e. W1-W2. This pathway was mapped by 27 DEGs during this time, and it was the highest 
number of DEGs among all the pathways and intervals (Figure 4.10 and Appendix 4) involved 
in WT. Pathways involved in NM showed that this strain had a higher number of mapped DEGs 
for purine and pyrimidine metabolism during the first interval, which decreased rapidly in the 
following intervals (Figure 4.10).  
ABC transporter system from environmental information process categories was highest during 
the second interval. There were five metabolic pathways such as amino sugar and nucleotide 
sugar metabolism, arginine and proline metabolism, fructose and mannose metabolism, 
glutathione metabolism, terpenoid backbone biosynthesis, where DEGs only from WT were 
mapped to different intervals (Appendix 4). Additionally, WT had the DEGs mapped to the 
protein export pathway during the first interval in the genetic information processing category 
(Appendix 4 d), which was not present in the MT.  
Comparison within the strain (MT) showed that the number of DEGs during the last two 
intervals was much lower than the first interval (Appendix 4 b) and comparatively lower than 
the WT. These DEGs were mapped to different metabolic pathways were categorized into 8 
secondary classifications such as amino acid metabolism (10 pathways), carbohydrate 
metabolism (9 pathways), energy metabolism (4 pathways), metabolism of terpenoids, and 
polyketides (4 pathways), nucleotide metabolism (2 pathways), lipid metabolism (2 pathways), 
other secondary metabolism (2 pathways), metabolism of cofactors and vitamins (1 pathway) 
(Appendix  4 e, f, g, h).  
All the pathways for carbohydrate metabolism and energy metabolism showed fewer mapped 
DEGs. The number of DEGs mapped to the pathways for glycolysis/gluconeogenesis, and 
pyruvate metabolism had sharply decreased after the first interval (Figure 4.10). The number 
of mapped DEGs belong to oxidative phosphorylation was 26 during the first interval, which 
was drastically lowered to 1 during the middle interval (Figure 4.10). However, the MT had 
shown some pathways that are not present in the WT strain, such as acarbose and validamycin 
biosynthesis, biosynthesis of vancomycin group antibiotics. Both cases mapped DEGs appear 
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only during the third interval, which roughly demonstrated that the mutant strain might have a 
different profile for antibiotic production and appeared lately (Appendix 4 g). Similarly, the 
number of mapped DEGs for nitrogen metabolism  and ABC transporter system had decreased 
significantly during the second and third intervals (Figure 4.10).  
 
Figure 4. 10: KEGG Mapping of the DEGs from within strain analysis. Y-axis denotes the 
number of mapped DEGs into the corresponding pathways. W1, W2 , W3 and W4 refers to the 
corresponding sampling day of the WT strain, and M1, M2,M3 and M4 refers to the sampling 
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5. Discussions  
5.1 RNA-Seq for DEG analysis 
RNA-Seq is now the most powerful and robust technology for genome-wide differential gene 
expression analysis. The analysis of the expression levels of all mRNAs in the transcriptome  
during cellular development can be a tool to elucidate regulatory pathways. Several 
transcriptomic studies used a mutant strain of Streptomyces to explain their gene expression 
pattern  (Bignell et al., 2005; Kato et al., 2002 and Medema et al., 2011). This thesis focuses 
on the gene expression pattern of the WT and MT strains. Analyzing the RNA-Seq data will 
make it easy to explain why the Acl producing WT and MT have different antibiotic synthesis 
profiles. In addition to this, GO enrichment analysis and KEGG pathway mapping of these 
DEGs may explain their functional categories and their expressed pathways to understand the 
recycling of Acl and why HO42 is an overproducer.  
After the emergence of NGS techniques, comparative transcriptome analysis has widened the 
scope to study the biosynthetic gene clusters in biologically relevant organisms (Amos et al., 
2017). There are multiple tools available for a defined RNAseq pipeline, yet it is always 
challenging to choose the appropriate tools suitable for the objectives. Optimizing the 
sequencing depth (reads per sample) for these studies is crucial and a significant aspect to 
consider during an experimental design.  Haas et al. (2012) suggested that the sequencing depth 
of 5-10 million rRNA depleted reads are enough to characterize the transcriptional activity 
from a wide variety of microbial species.  In this study, average sequencing depths were 16.4 
million (WT) and 15.3 million (MT). A much higher sequencing depth (> 30 million) can create 
noise from the highly expressed genes, although it can detect the transcripts with significantly 
lower abundance. In contrast, lower sequencing depth keeps these low abundance transcripts 
undetected (Tarazona et al., 2011).  
Estimation of within-group variability is necessary for making inferences about the conditions. 
The use of biological samples or replicates from different backgrounds is useful to draw such 
inferences (Auer & Doerge, 2010 and Fang & Cui, 2011). However, due to financial and 
technical constraints, researchers have to keep the number of biological replicates small (Auer 
& Doerge, 2010; McCarthy et al., 2012 and Zhao et al., 2016).  Therefore, it is always critical 
to optimize the experimental design by balancing the sequencing depth and biological 
replicates (Auer & Doerge, 2010 and Fang & Cui, 2011). Pooling the RNA-Seq data from 
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different samples can mitigate the issue with an unbiased gene expression profile.  Assefa et 
al. (2020) suggested that pooling of the samples can detect the biological effect of interest by 
retaining the variability of the sample.  It is preferable to use three biological replicates for each 
experimental condition. Although three biological replicates due to economic limitations, they 
were pooled together. According to the edgeR (Robinson et al., 2010) manual, dispersion value 
was set to 0.01 because the samples were pooled and variability was counted (Yunshun et al., 
2020).  
In this experiment, time course DGE within the strain with 24hr intervals showed us the up and 
downregulation of primary and secondary metabolic pathways. Secondary metabolism is 
strongly connected to primary metabolism. Precursors and cofactors for secondary metabolites 
are derived from processes in the central carbon metabolism. However, precursor units might 
be synthesized through the degradation of stored macromolecules. Evidence suggested that the 
degradation of fatty acids and branched-chain amino acids (BCAAs) has been suggested to 
contribute to the acetyl-CoA supply for certain PKs in Aspergillus species (Richter et al., 
2014). Comparative analysis of regulatory genes (for example) may positively associate with 
higher production of Acl B in MT.  
 
5.2 Predicted pathways in WT 
The biosynthetic pathways for producing natural products e.g. antibiotics are often encoded by 
the genes living in close proximities and organized as BGCs. Their organization follows a 
highly conserved logic. With the help of this gene conservation logic, genome mining identifies 
the core bioactive molecules by homology searching (Blin et al., 2019).  Genes from these 
clusters are involved in precursor molecule biosynthesis, compound scaffold assembly, and 
modification. Besides these core functions, occasionally, genes for resistance, transport, and 
regulation are also involved (Nützmann et al., 2016). A review study on BGC in Streptomyces 
had shown that the genomes could carry 8-83 BGCs (mean = 39.64 and SD = 11.40) (Belknap 
et al., 2020). In this experiment, antiSMASH detected 33 BGCs in the WT genome. The 
computational identification of the BGCs starts from the core enzymes produced by core 
biosynthetic genes (for Acl producing BGC, gene ID:  fig_33899.16.peg.2277 and 
fig_33899.16.peg.2278; mentioned Table 4.3), involved in the SM synthesis pathway. pHMM 
is a probabilistic model which was used by antiSMASH to detect this core catalytic molecule 
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producing genes.  In the next step, by using manually curated BGC cluster rules, antiSMASH 
detected the other core genes (e.g. additional biosynthetic genes, genes related to 
transportation, regulatory genes, and other accessory genes) (Figure 4.3) (Blin et al., 2019). 
However, many of those genes that reside in this predicted BGC were well characterized (Table 
1.2).  
Many Streptomyces contain particular BGCs responsible for synthesizing aromatic polyketide, 
which involves spore pigmentation (Iftime et al., 2016) and induced during sporulation of aerial 
hyphae or as an indication of initiation of stationary phase (Kelemen et al., 1998). Among the 
31 predicted BGCs throughout the WT genome, region 1.25 (Table 4.2) showed similarity with 
multiple BGCs responsible for the synthesis of spore pigmenting polyketide e.g. BGC0000271 
(Omura et al., 2001) and BGC000272 (Martin et al., 2001) with 83% and 85% similarity. 
Comparing the DEG data from within the strain analysis (appendix 8) likely demonstrate how 
these two strains i.e. WT and MT may differ from each other about the onset of sporulation 
and entering the stationary growth. The predicted region spans between the gene IDs 
fig:33899.16.peg.7322 to fig:33899.16.peg.7394. The DEG analysis clearly shows that a group 
of genes involved in transport related activities were upregulated during the last two intervals. 
However it must be noted that most of these DEGs had comparatively much higher  
upregulation. Since in-depth analysis of this BGC was not part of the thesis plan, it should be 
addressed in future experiments.  
5.3 DE of the regulators 
Although there are local and global regulators to influence the synthesis of an antibiotic, 
typically, genes inside the corresponding BGC have a superior effect on the production of the 
relevant antibiotic (Liu et al., 2013). In addition to eliciting regulatory effects, some other genes 
within a BGC can also encode enzymes that catalyze the reaction for antibiotic formation (Wei 
el al., 2018). These regulatory genes are often termed as cluster situated regulators (CSRs) (Liu 
et al., 2013 and Wei et al., 2018). However, the regulatory effects of those genes within the 
genome can exert upon an antibiotic producing BGC in a pathway-specific manner; they can 
also regulate the expression of the genes residing outside the BGC (Niu & Tan, 2013). 
In contrast to this, pleiotropic regulators residing outside of the BGCs can also regulate the 
production of multiple antibiotics in addition to morphological development of the respective 
organism. Another type of regulator that can regulate the central metabolic system and those 
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regulatory genes mentioned above. They are termed as global regulators and situated 
throughout the genome (Liu et al., 2013). Sigma factors and other related mechanisms, e.g. 
anti-sigma and anti-anti-sigma factors, contributed to an alternative regulation mode that 
commonly regulates antibiotic production in Streptomyces sp. (Zhou et al., 2011). There are 
approximately 97 sigma factors, and such genes reside throughout the WT genome, of which 
few are just up and downstream of the predicted Acl producing BGC. This suggests a sigma 
factor-based regulation might exist in Streptomyces (Pinilla et al., 2019). A regulator of sigma 
factor (gene ID=fig|33899.16.peg.2336) resides just downstream of the predicted Acl 
producing BGC was upregulated on day 2 (LogFC: 1.37) and day 3 (LogFC: 1.23). Since both 
WT and MT were grown in the same environment, this differentiation should not arise from 
environmental factors such as nutrition and temperature. However, sigma factors 
transcriptionally control the sporulation and other responses due to stress in bacteria e.g. 
Bacillus sp. (Zhou et al., 2011).  
5.4 Topmost DEGs 
The 20 most up and downregulated genes are listed in appendix 1, and no DEG was reported 
from the Acl gene cluster when the comparison comes from between the strain. Additionally, 
many of the highly regulated genes were uncharacterized (hypothetical protein). Genes 
classified as hypothetical are predicted to code for proteins in an organism, but no experimental 
evidence for their function for the entire protein family (Ijaq et al., 2019). Streptomyces 
coelicolor is considered a model organism for antibiotic-producing bacteria. but about 34% of 
its predicted protein-coding genes were hypothetical (Alam et al., 2011). 
One of the highly upregulated gene (fig|33899.16.peg.679) on D1 was a putative GT (appendix 
1ai). This enzyme acts as a drug-tailoring tool and is involved in the glycosylation of natural 
products. Experimental evidence suggests that NDP-activated sugars were utilized by GT  and 
stereo specifically transfer the sugar residue to the aglycone (Nguyen et al., 2010 and Salem et 
al., 2017). Long-chain-fatty acid-CoA ligase (fig|33899.16.peg.5946) activates the oxidation 
of complex fatty acids, and with the help of ATP and CoA, catalyzes the formation of fatty 
acyl-CoA (Watkins, 1997). It was also one of the most upregulated genes on D2 and D4, and 
other genes such as polyketide synthase modules and related proteins (fig|33899.16.peg.5943), 
ABC transporter permease protein 2 (fig|33899.16.peg.2475) (appendix 1aii and aiv).  
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5.5 DEGs of the Acl producing cluster 
Genes residing inside the Acl producing BGC were differentially expressed  and listed in Table 
4.3 and 4.4. The TIGR04222 domain-containing membrane protein (gene ID: 
fig|33899.16.peg.2253) in the MT strain showed an intriguing expression pattern (Table 4.4). 
It had a predominantly higher expression during the first interval i.e. D1-D2, compared to the 
WT strain. This gene is may contribute to self-immunity by regulating the toxic activity (Baba 
& Schneewind, 1998; Flaherty et al., 2014).  
The gene for trypsin-like protease (TLP)/serin protease (gene ID: fig|33899.16.peg.2260) had 
shown an distinguished pattern of expression. In contrast to MT, it was upregulated at the first 
time point in WT. However, between the strain comparison shows that this gene was 
significantly downregulated after initial upregulation (Table 4.4). The secretion of proteolytic 
enzyme e.g. serin protease by Streptomyces is often shown at the onset of secondary 
metabolism. Thus, antibiotic synthesis and serine protease formation are coordinately regulated 
(Ginther, 1979).  
Polyketide chain length factor (PCLF) (gene ID: fig|33899.16.peg.2277) forms a complex with 
β-keto acyl synthase (KS) (gene ID: fig|33899.16.peg.2278) and an acyl carrier protein (ACP) 
(gene ID: fig|33899.16.peg.2276) and makes up the minimal PKS. Within strain analysis 
(Table 4.3) demonstrated that genes involved in the process mentioned above were expressed 
differently between the strains (Table 4.3 and 4.4). This minimal PKS complex determines the 
PKS product's length (Bisang et al., 1999; Watanabe & Ebizuka, 2004). Other accessory genes 
(in addition to minimal PKS) required for the synthesis of the intermediate aklavinone are 
polyketide ketoreductase (gene ID: fig|33899.16.peg.2280), monooxygenase (gene ID: 
fig|33899.16.peg.2279) and aromatase (gene ID: fig|33899.16.peg.2281) (Räty et al., 2002b). 
These three genes had shown a similar pattern in both DEG analyses (Table 4.3 and 4.5), and 
except polyketide ketoreductase and monooxygenase, the other four genes did not show 
significant changes during intermediary duration i.e. D2-D3 (Table 4.3). Initially, nogalonic 
acid methyl ester cyclase (gene ID: fig|33899.16.peg.2271) was more downregulated in WT 
but upregulated later. Although MT had shown a similar trend in expression, the magnitude 
was lower than WT. This cyclase controls the stereochemistry of anthracyclines in 
Streptomyces nogalater (Torkkell et al., 2000). The above-mentioned data apparently suggests 
that the WT strain has an efficient system for aklavinone production. 
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The tetracyclic aklavinone is glycosylated by a glycosyltransferase (encoded by aknS) (gene 
ID: fig|33899.16.peg.2293) and transfers the first deoxyhexose. An in vitro study suggests that 
its nearby the gene aknT (gene ID: fig|33899.16.peg.2292) strongly increases the expression of 
aknS, but it had expressed poorly in the absence of this activating gene (Lu et al., 2005). 
Although the influencing role of aknT in this study was not detected but  this gene-couple had 
showed observable differences, as mentioned earlier. However, DE of aknT in the MT strain 
was not significant at the later stage of growth.  
 
5.6 GO enrichment analysis of DEGs 
The characteristics of the biological attribute of the RNA-seq data can be identified by GO. I 
performed the GO classification and enrichment analysis based on data from the strain 
comparison, i.e. WT vs. MT. After that, GO enrichment analysis (P < 0.05) for the up and 
downregulated genes was completed and categorized into different functional classes. I have 
listed the top 30 GO classes (appendix 3). The more general GO annotations of the DEG 
between the strain from different days were in Figure 4.5. DEG on day 3 showed the highest 
number of annotated genes, e.g. ATP binding, DNA binding, metal ion binding, hydrolase 
activity, ATPase activity, etc., that belongs to MF. The annotated genes for BP showed that 
genes involved in the oxidation-reduction process were predominantly higher than other 
annotated genes throughout the growth cycle (appendix 3e-h), which demonstrate 
oxidoreductase activity and the control of oxidative stress (Pinilla et al., 2019). The CC 
ontology terms were used to annotate the cellular location of the gene products. In this 
experiment, it has been observed that a significant portion of the DEGs was annotated to 
“integral component of membrane” (appendix 3: i-l) thus, It can be hypothesized that the 
product of most of the DEGs has at least some parts of their peptide embedded in the 
hydrophobic region of the membrane (Caspi et al., 2018). Among other annotated GO terms in 
the CC category, the ABC transporter complex forms the central pore through the plasma 
membrane and transports the metabolites throughout the cell (Roncaglia et al., 2013). This 
complex enables the transport of the antibiotic through the cell membrane to ATP hydrolysis 
and contributes to self-resistance against the produced antibiotics (Méndez & Salas, 2001). 
The gene category overrepresentation analysis is a simple but widely used method to highlight 
any BP (Young et al., 2010). WT is enriched with the genes involves in oxidoreductase activity. 
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In general, BGCs contain multiple oxidoreductase encoding genes, which play a critical role 
during the synthesis of its related natural product (Scott & Piel, 2019). 
The upregulated genes involved in different hydrolase activity were enriched on day three 
(Figure 4.6b). Hydrolase enzymes catalyzed the bond cleavage reaction, e.g. aminolysis, 
esterification, polymerization, transesterification; by using water as a nucleophile (Paul & 
Fernández, 2016). It is suggested that the hydrolytic activity of different hydrolase enzymes 
has a correlation with the antibiotic synthesis. Hydrolytic activities such as protease, nuclease, 
amylase in streptomycin, novobiocin, levorin, and oleandomycin producing actinomycetes 
were significantly changed during the development of the cultures (Baskakova et al., 1981). In 
gram-positive bacteria, a tightly organized interplay of hydrolytic and biosynthetic enzymatic 
activities actively remodeled the cell wall macromolecule peptidoglycan. This cell wall 
remodeling partially possess by hyphae and spore formation are significantly influenced by 
cell hydrolase enzymes, Out of 56 candidate cell wall hydrolase genes in Streptomyces 
coelicolor identified in silico, seven expressed during vegetive growth and sporulation (Haiser 
et al., 2009). Gene enrichment analysis of my transcriptomic data showed that WT is enriched 
by genes with hydrolase activity on D3, which is possibly the outcome of its efficient cell 
differentiation. Additionally, WT also showed superior hydrolase activity on glycosyl bonds 
and catalytic activity (Figure 4.6b).  
The cellular component of the enriched genes that were upregulated shows that on D1 and D4, 
the upregulated genes exclusively enriched the membrane part. In addition to this, some more 
sub-cellular regions, e.g. intrinsic and integral components of the membrane, were enriched in 
WT (Figure 4.6c). The hypha tip is considered an important area where membrane protein and 
lipids may be secreted (Flärdh & Buttner, 2009). Additionally, experiments suggested that 
secondary metabolism and cell differentiation are related in some Streptomyces (Li et al., 2006 
and Ou et al., 2008) because membrane-bound enzymes catalyze the synthesis of cell-wall 





5.7 KEGG pathway mapping of the DEGs 
Researchers get systematic insight into gene lists generated from omics-based experiments by 
pathway enrichment analysis which identifies biological pathways enriched with the listed 
genes significantly (Reimand et al., 2019). Among other tools, scientists used KEGG pathway 
enrichment analysis tools in their experiments to get an overview of the metabolic network of 
different microorganisms (Jia et al.,, 2017; Malik et al., 2020; Shen et al., 2020).  
The DEGs from within the strain and between the strain comparisons were annotated to KEGG 
pathways. Global and overview mapping of DEGs from the comparison between the strain 
showed that most of the annotated DEGs were from days 2 and 3. DEGs from the “within the 
strain” comparison demonstrated a similar pattern, that means the annotated genes come from 
mostly during the intermediate sampling time (Figure 4.7). The comparison between the strains 
demonstrated that different metabolic pathways related to primary metabolism, e.g. carbon, 
amino and fatty acids that could affect the secondary metabolism and biosynthesis of cofactors, 
were higher in WT than MT. It has known that the source of carbon influences secondary 
metabolite production and can act on different levels. Additionally, this influence directed the 
flow of carbon atoms to precursor amino acid, side-chain precursors (Rokem et al., 2007).  
Streptomyces utilize both glutamate and aspartate as sources of carbon and nitrogen (Corvini 
et al., 2004). They also play a critical role in the central nitrogen metabolism (Hodgson, 2000). 
Aspartate transaminase transferred the amine group of aspartate to glutamate (Hodgson, 2000), 
and the carbon chain of glutamate and aspartate enters the TCA cycle after deamination 
(Borodina et al., 2005). Alanine is considered to be a very important amino acid for 
Streptomyces due to its significant contribution to protein biosynthesis, peptidoglycan 
synthesis (Borodina et al., 2005).  DEGs (between the strain) mapped to alanine, aspartate and 
glutamate  metabolism showed a clear indication that the number of DEGs involved into these 
pathways are increased (Figure 4.9a). However, it is also observed that the number of mapped 
DEGs in this metabolic class is dominated by the downregulated genes. Such as, aspartate 
aminotransferase (EC 2.6.1.1) catalyzes a reversible transfer of an amino group between 
aspartate and glutamate (Appendix 5). It also demonstrated that enzymes e.g. EC 6.3.1.2, EC 
3.5.1.2 and EC1.4.1.13  multiple pathways directly connected with  L-glutamate were mapped 
with downregulated DEGs.  (Appendix 5).  
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Several carbohydrates-related metabolic pathways e.g. TCA cycle, glycolysis, pyruvate was 
also enriched by the DEGs (Figure 4.9b). Actinorhodin (ACT) is a type II polyketide produced 
by Streptomyces coelicolor A3(2) (Itoh et al., 2007). Gene deletion experiment of glucose-6-
phosphate dehydrogenase and phosphoglucomutase (PGM), and overexpression of acetyl 
coenzyme A carboxylase (ACCase) revealed that glucose-6-phosphate dehydrogenase plays an 
important role by regulating the carbon flux to ACT production. In contrast, PGM deletion 
resulted in glycogen overproduction coupled with lower ACT production. However, an 
efficient and increased supply of glucose to the ACT pathway can be achieved after 
overexpression of ACCase (Ryu et al., 2006). Mapped data of the DEGs obtained from D2 
showed that the downregulated gene PGM was mapped to the reversible conversion of glucose-
1-phosphate and glucose-6-phosphate. It should be noted that most of the catalysts involved in 
the Embden-Meyerhof pathway (appendix 10) were downregulated; hence WT was reported 
to produce Acl, and upregulated gene ACCase was also mapped to the glycolytic pathways. 
Therefore there are certainly a diversion of carbon flow than expected. Phosphoglucose 
isomerase directs the carbohydrate catabolism to TCA cycle, subsequently create precursor 
molecules for secondary metabolite formation (Salas et al., 1984). However, gene encode this 
enzyme didn’t map to glycolysis metabolic pathway at any time point (data not shown) also 
suggests that this gene might have a stable expression.  
A pan genomic study on Streptacidiphilus revealed that core genes (Callister et al., 2008) 
mainly were mapped to the ribosome, purine metabolism, and oxidative phosphorylation 
pathways (Kim et al., 2015; Malik et al., 2020). KEGG mapping of the DEGs had shown a 
similar result as these pathways have one of few of the highest number of mapped genes over 
other metabolic pathways in my data (Figure 4.9).  
It has also been observed that all the 17 strains of Streptacidiphilus showed the highest number 
of mapped gene in ABC transporter (Malik et al., 2020). Streptomyces secreted the antibiotics 
through the cell membrane as part of its self-defense mechanism. Along with other molecules, 
ABC transporter system aids this secretory mechanism and also represents the largest protein 
family (Wilkens, 2015). Similarly,  KEGG mapping has showed that highest number of the 
DEGs were mapped to “ABC transporter” (Figure 4.9d). 
The two-component system (TCS) is a signal transduction system that helps Streptomyces to 
cope with the ever-changing environment. TCS acts as pleiotropic regulator for more than one 
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antibiotic production (Rodríguez et al., 2013). Experiments suggested that TCS regulate the 
production of their respective antibiotics through some signal molecules, e.g. phosphokinase, 
or nutritional signal through carbon/nitrogen/phosphate or carbon/nitrogen ratio or pH value. 
The mapping of the DEGs for two-component shows that this system was enriched on day 
three. Carbon metabolism was slightly lower during this time (Figure 4.8a), but nitrogen 
metabolism was higher on day three (Figure 4.9c).  
Comparative DEG within the strain of WT and MT (Figure 4.1b) shows that the number of 
DEGs in MT was much lower at the last two intervals. The number of upregulated genes was 
much lower than M2-M3, which reflects mapping of these DEGs into different KEGG 
pathways. However, the number of downregulated genes was higher in several cases. 
Surprisingly, the number of DEGs in the last interval, i.e., M3-M4, was reversed. Additionally, 
many of those up/downregulated genes during M2-M3 were reversed at M3-M4. This depicts 
a scenario where a metabolic switching might take place in the mutant strain during this 
transition period, and therefore the number of significant DEGs was few.  
Due to very a smaller number of DEGs during the last two intervals in MT strain i.e. M2-M3 
and M3-M4 (appendix 4e), which demonstrated a fact that most part of the MT genome  have 
a steady transcriptional activity. In house experiment on MT strain showed that it can produce 
anthracycline for a prolonged period of time (>10 days).   The mutant strain also demonstrated 
a lack of oxidative phosphorylation (Figure 4.10), which means it was under continuous 
oxidative stress. Although it depends upon the species which type of metabolism will dominate 
throughout their growth (Millan-Oropeza et al., 2017), seemingly, the mutant strain shows low 
glycolytic and oxidative metabolism (Figure 4.10) at the later stage of growth since they did 
not show significant differential expression. 
Although the mutant strain shows a relatively low number of DEGs during M2-M3 and M3-
M4 intervals, most of those DEGs were mapped into different pathways such as biosynthesis 
of acarbose and validamycin biosynthesis, streptomycin, vancomycin, type II polyketide 
backbone and polyketide sugar unit, and tetracycline (Appendix 4g). In its chemical structure, 
vancomycin is a glycopeptide antibiotic that is synthesized via non-ribosomal peptide assembly 
(Yim et al., 2014).  However, differences in the pathway annotations of DEGs to these 
pathways do not explicitly confirm their synthesis of those metabolites. Hence, it is required to 
test a hypothesis that why the DEG were mapped to some other metabolites only in MT 
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although it had remarkably low number of DEGs. The DEGs from M3-M4 were mapped to the 
pathways for type II polyketide backbone (appendix 6) and polyketide sugar unit (appendix 7) 





Results of the present study would make a better understanding of the gene expression pattern 
between the WT and MT strains and provide several genes and pathways for further 
investigation. The differential expression of some genes, e.g. TIGR04222 domain-containing 
membrane protein, serine protease, hypothetical protein (gene ID: 
fig|33899.16.peg.2270)/transcriptional regulator, nogalonic acid methyl ester cyclase, aknC, 
aknX, aknA, aknE1, aknT, and aknS residing inside the Acl producing BGC from the 
experimental strains throughout their growth cycle provide a better insight on Acl biosynthesis. 
This study also demonstrates a possible role of a nearby global transcriptional regulator 
(sigma), which should be studied along with other global regulators. Although GO enrichment 
analysis did not make any conclusive remarks, it clearly shows the functional classifications of 
the DEG between the strains. The KEGG pathway mapping of the DEGs showed  that most of 
the mapped pathways were enriched on D2 and D3. The lower number of mapped genes in 
pantothenate and CoA biosynthesis, glycolysis, oxidative phosphorylation, two-component 
system, and ABC transporter pathways in the mutant strain need further analysis. 
There were a few shortcomings in this study, some of which are outside the scope of this thesis 
work, that make drawing concrete conclusions from the results challenging. There was a high 
percentage of transcripts that are aligned with the WT genome multiple times possibly due 
existence of rRNA transcripts even after rRNA depletion. So there is a possibility of that the 
sequencing depth was not optimized that ultimately reflected in the DGE analysis. 
Additionally, DEG analysis did not consider mutations in the recycling genes and that is 
certainly beyond the scope of this thesis work and should be addressed in a future study. 
Additionally, the effect of a gene finally reflects after its translation. So  a study on their 
translatome might broaden the understanding of the recycling gene(s). The signal from rare 
transcripts which may be involved in recycling should be analyzed by increasing the 
sequencing depths. A large portion of the annotated genes throughout the WT genome, within 
and nearby the Acl BGC were uncharacterized (hypothetical genes) and demonstrates lack of 
annotation and makes this study a formidable task. It is also visible from DEG list that a large 
portion of list contains hypothetical protein (appendix 9).  These hypothetical proteins  need to 
be characterized for better GO analysis and KEGG pathway mapping. A WT genome with 
better annotations can help in the discovery of new structure and functions of a protein which 
ultimately allow us to discover additional protein pathways. A much better interpretation of 
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hypothetical proteins can lead us to an improved GO enrichment and KEGG pathway mapping 
analysis. In this current situation KEGG mapping apparently make more sense than GO 
enrichment because it clearly shows the significant pathways where the DEGs are mapped into. 
However, GO enrichment analysis sometimes beneficial if the objective is to determine any 
certain state of an organism e.g. when it utilizes more carbohydrates. Such assertion can make 
a clearer picture over an organism but not enough to make an appropriate conclusion. Finally, 
an improved genome annotation and further molecular experiments, computational and gene 
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Appendix 1  
list of top 20 genes those are up and downregulated most. 
a) Between the strains (WT Vs MT) 
i) Day 1 
Gene ID Length LogFC Gene product 
fig|33899.16.peg.4096 456 8.540331 Hypothetical protein 
fig|33899.16.peg.1277 825 8.006175 putative tyrosinase 
fig|33899.16.peg.4311 153 7.714794 Hypothetical protein 
fig|33899.16.peg.679 1581 7.714794 Putative glycosyltransferase 
fig|33899.16.peg.508 1614 7.257936 alpha-L-arabinofuranosidase II  
fig|33899.16.peg.546 450 7.128077 Hypothetical protein 
fig|33899.16.peg.3941 618 6.846037 Hypothetical protein 
fig|33899.16.peg.5923 1329 6.846037 Hypothetical protein 
fig|33899.16.peg.5946 408 6.846037 Long-chain-fatty-acid--CoA ligase 
fig|33899.16.peg.5948 1074 6.846037 CrtT-methyltransferase-like 
protein 
fig|33899.16.peg.1637 1185 -9.2381 Hypothetical protein 
fig|33899.16.peg.1646 807 -9.89699 Hypothetical protein 
fig|33899.16.peg.1642 1725 -9.93482 C-5 cytosine-specific DNA 
methylase family protein 
fig|33899.16.peg.1700 249 -9.98617 Hypothetical protein 
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fig|33899.16.peg.1690 318 -10.0496 Hypothetical protein 
fig|33899.16.peg.1702 444 -10.2125 Phage protein 
fig|33899.16.peg.1692 435 -10.9228 Hypothetical protein 
fig|33899.16.peg.1681 1161 -11.0763 Hypothetical protein 
fig|33899.16.peg.3899 696 -11.2149 Hypothetical protein 
fig|33899.16.peg.1685 558 -12.1678 Hypothetical protein 
 
ii) Day 2 
Transcript Id Length LogFC Gene product 
fig|33899.16.peg.5924 1635 8.481446 Polyketide synthase modules and 
related proteins 
fig|33899.16.peg.5946 408 8.068018 Long-chain-fatty-acid--CoA ligase 
fig|33899.16.peg.1866 957 7.831675 Multicopper oxidase 
fig|33899.16.peg.564 603 7.831675 Capsular polysaccharide biosynthesis 
protein 
fig|33899.16.peg.5947 135 7.761602 Hypothetical protein 
fig|33899.16.peg.8368 150 7.761602 Hypothetical protein 
fig|33899.16.peg.5566 804 7.438068 Extracellular ribonuclease Bsn 
fig|33899.16.peg.2475 831 7.348779 ABC transporter permease protein 2 
fig|33899.16.peg.6551 1329 7.218092 lpha-glucosides-binding periplasmic 
protein AglE precursor 
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fig|33899.16.peg.2218 396 7.151316 Guanyl-specific ribonuclease  
fig|33899.16.peg.1645 372 -7.32031 Hypothetical protein 
fig|33899.16.peg.4803 495 -7.48284 Hypothetical protein 
fig|33899.16.peg.1700 249 -7.58184 Hypothetical protein 
fig|33899.16.peg.1702 444 -7.71865 Phage protein 
fig|33899.16.peg.1697 435 -7.88297 Hypothetical protein 
fig|33899.16.peg.4542 120 -7.88297 Hypothetical protein 
fig|33899.16.peg.6153 1173 -8.09893 Hypothetical protein 
fig|33899.16.peg.1628 243 -8.34427 Hypothetical protein 
fig|33899.16.peg.4813 789 -9.31352 Transcriptional regulator 
fig|33899.16.peg.4815 432 -10.3267 putative regulatory protein 
 
iii) Day 3: 
Transcript ID length LogFC Gene product 
fig|33899.16.peg.2475 831 7.828807 ABC transporter permease protein 2 
fig|33899.16.peg.6703 699 7.279224 Putative oxidoreductase 
fig|33899.16.peg.540 462 7.180351 Hypothetical protein 
fig|33899.16.peg.1089 324 7.070788 Alpha-amylase inhibitor HAIM II 
precursor 
fig|33899.16.peg.1156 1050 6.698898 Sorbitol dehydrogenase 
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fig|33899.16.peg.5002 981 6.548437 Hypothetical protein 
fig|33899.16.peg.5937 1053 6.427157 Endo-1 4-beta-xylanase  
fig|33899.16.peg.4373 888 6.380437 Hypothetical protein 
fig|33899.16.peg.541 519 6.380437 Mobile element protein 
fig|33899.16.peg.565 321 6.380437 Hypothetical protein 
fig|33899.16.peg.1698 534 -7.17393 hypothetical protein 
fig|33899.16.peg.5964 1065 -7.17963 transport regulator 
fig|33899.16.peg.4814 432 -7.29101 Nudix hydrolase family protein 
fig|33899.16.peg.4816 384 -7.30706 hypothetical protein 
fig|33899.16.peg.1697 435 -7.31747 hypothetical protein 
fig|33899.16.peg.8545 1047 -7.96393 ABC transporter substrate-binding 
protein  
fig|33899.16.peg.4813 789 -9.98776 Transcriptional regulator KorSA 
GntR family 
fig|33899.16.peg.1637 1185 -10.0425 hypothetical protein 
fig|33899.16.peg.1629 192 -10.8658 hypothetical protein 







iv) Day 4 
Transcript ID length LogFC Gene product 
fig|33899.16.peg.5949 387 9.356733 hypothetical protein 
fig|33899.16.peg.797 534 9.128841 hypothetical protein 
fig|33899.16.peg.6552 1362 8.977472 ABC alpha-glucoside transporter inner 
membrane subunit AglF 
fig|33899.16.peg.8368 150 8.524464 hypothetical protein 
fig|33899.16.peg.2475 831 8.249654 ABC transporter permease protein 2 
fig|33899.16.peg.5946 408 8.058871 Long-chain-fatty-acid--CoA ligase 
fig|33899.16.peg.5943 3951 7.970473 Polyketide synthase modules and 
related proteins 
fig|33899.16.peg.6551 1329 7.941416 Alpha-glucosides-binding periplasmic 
protein AglE precursor 
fig|33899.16.peg.6553 840 7.777146 Alpha-glucoside transport system 
permease protein AglG 
fig|33899.16.peg.5945 1053 7.700258 hypothetical protein 
fig|33899.16.peg.1646 807 -8.82861 hypothetical protein 
fig|33899.16.peg.1690 318 -9.32519 hypothetical protein 
fig|33899.16.peg.1700 249 -9.38399 hypothetical protein 
fig|33899.16.peg.1636 939 -9.39547 hypothetical protein 
fig|33899.16.peg.1701 321 -9.9094 hypothetical protein 
fig|33899.16.peg.4813 789 -10.0395 Transcriptional regulator  
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fig|33899.16.peg.1702 444 -10.152 phage protein 
fig|33899.16.peg.727 171 -10.2501 hypothetical protein 
fig|33899.16.peg.1629 192 -10.5045 hypothetical protein 
fig|33899.16.peg.2966 1749 -10.6837 ABC transporter permease protein 1 
 
b) Within the strain 
i) Comparison between day 1 and 2 within MT.  
Transcript ID length LogFC Gene product 
fig|33899.16.peg.2253 651 10.92496 Hypothetical Protein 
fig|33899.16.peg.6551 1329 10.7782 Alpha-glucosides-binding periplasmic protein 
AglE precursor 
fig|33899.16.peg.796 969 9.802582 ABC transporter ATP-binding protein 
fig|33899.16.peg.6552 1362 9.714246 ABC alpha-glucoside transporter inner 
membrane subunit AglF 
fig|33899.16.peg.555 369 9.519479 UPF0145 protein SCO3412 
fig|33899.16.peg.8061 741 8.842586 Hypothetical Protein 
fig|33899.16.peg.8078 897 8.521443 Universal stress protein 
fig|33899.16.peg.6550 1674 8.403135 Alpha-glucosidase AglA 
fig|33899.16.peg.6553 840 8.403135 Alpha-glucoside transport system permease 
protein AglG 
fig|33899.16.peg.5558 1158 8.340132 Acyl-CoA dehydrogenase 
fig|33899.16.peg.5163 879 -5.1501 Uncharacterized metal-dependent hydrolase 
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fig|33899.16.peg.5162 411 -5.50215 Hypothetical protein 
fig|33899.16.peg.509 1647 -5.60125 alpha-galactosidase  
fig|33899.16.peg.4714 741 -5.88076 Carbonic anhydrase 
fig|33899.16.peg.2256 1608 -5.9352 Long-chain-fatty-acid--CoA ligase 
fig|33899.16.peg.4608 1596 -6.39027 Two-component system sensor histidine 
kinase 
fig|33899.16.peg.4748 1197 -6.4698 Protease 
fig|33899.16.peg.2257 1671 -6.80255 Acetyl-CoA synthetase 
fig|33899.16.peg.4746 732 -7.05743 GlnR-family transcriptional regulator 
fig|33899.16.peg.4747 210 -8.72599 Hypothetical protein 
 
ii) Comparison between day 2 and 3 in MT: 
Transcript ID length LogFC Gene product 
fig|33899.16.peg.1833 942 2.894544 Cobalt-zinc-cadmium resistance 
protein CzcD 
fig|33899.16.peg.5162 411 2.423708 Hypothetical Protein 
fig|33899.16.peg.7186 1293 2.34684 Maltodextrin ABC transporter 
substrate-binding protein MdxE 
fig|33899.16.peg.5163 879 1.727672 Uncharacterized metal-dependent 
hydrolase 




fig|33899.16.peg.4615 2535 1.541028 Uncharacterized MFS-type transporter 
fig|33899.16.peg.5788 162 1.254255 Hypothetical Protein 
fig|33899.16.peg.6024 1017 1.219531 Dihydrofolate reductase 
fig|33899.16.peg.7955 549 0.97958 Dihydrofolate reductase  
fig|33899.16.peg.1331 2016 0.800832 putative secreted protein 
fig|33899.16.peg.8073 747 -3.83974 Pyruvate formate-lyase activating 
enzyme  
fig|33899.16.peg.8055 492 -3.86239 hypothetical protein 
fig|33899.16.peg.1615 579 -3.87184 hypothetical protein 
fig|33899.16.peg.1240 318 -3.93568 tRNA 2-thiouridine synthesis protein 
TusE 
fig|33899.16.peg.8090 3699 -4.00232 Respiratory nitrate reductase alpha 
chain 
fig|33899.16.peg.8076 1215 -4.14794 Flavohemoglobin / Nitric oxide 
dioxygenase 
fig|33899.16.peg.1239 474 -4.1796 NADH dehydrogenase 
fig|33899.16.peg.7669 2736 -4.41368 hypothetical protein 
fig|33899.16.peg.8041 1023 -4.57976 Alcohol dehydrogenase 






iii) Comparison between day 3 and 4 within MT 
Transcript ID length LogFC Gene product 
fig|33899.16.peg.7669 2736 5.51832 Hypothetical protein 
fig|33899.16.peg.8041 1023 5.514733 Alcohol dehydrogenase 
fig|33899.16.peg.8055 492 5.349423 Hypothetical protein 
fig|33899.16.peg.1239 474 5.246739 NADH dehydrogenase 
fig|33899.16.peg.1240 318 5.162008 tRNA 2-thiouridine synthesis protein 
TusE 
fig|33899.16.peg.8076 1215 5.070977 Flavohemoglobin / Nitric oxide 
dioxygenase 
fig|33899.16.peg.8090 3699 4.99111 Respiratory nitrate reductase alpha chain 
fig|33899.16.peg.8099 279 4.867178 Respiratory nitrate reductase alpha chain  
fig|33899.16.peg.8073 747 4.748733 Pyruvate formate-lyase activating 
enzyme  
fig|33899.16.peg.8048 2730 4.647366 Protein lysine acetyltransferase Pat 
fig|33899.16.peg.5163 879 -1.46046 Uncharacterized metal-dependent 
hydrolase 
fig|33899.16.peg.5283 630 -1.88018 Hypothetical Protein 
fig|33899.16.peg.7417 1479 -2.0434 Ricin-type carbohydrate-binding domain 
fig|33899.16.peg.5162 411 -2.21934 Hypothetical Protein 
fig|33899.16.peg.4718 174 -2.39556 Hypothetical Protein 
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fig|33899.16.peg.1833 942 -2.575 Cobalt-zinc-cadmium resistance protein 
CzcD 
fig|33899.16.peg.7186 1293 -2.60631 Maltodextrin ABC transporter substrate-
binding protein MdxE 
fig|33899.16.peg.3687 2310 -3.82072 beta-glucosidase 
fig|33899.16.peg.2977 966 -6.4855 D-3-phosphoglycerate dehydrogenase  
fig|33899.16.peg.6631 903 -6.86873 Ectoine hydroxylase  
 
iv) Comparison between day 1 and 2 in WT 
Transcript ID  length LogFC Gene product 
fig|33899.16.peg.4280 2226 9.880863 Integral membrane protein 
fig|33899.16.peg.797 534 9.422005 Tripartite tricarboxylate transporter TctB 
family; 
fig|33899.16.peg.679 1581 8.350327 hypothetical protein 
fig|33899.16.peg.4311 153 8.161912 hypothetical protein 
fig|33899.16.peg.799 396 8.103228 UspA domain protein 
fig|33899.16.peg.680 483 7.649496 hypothetical protein 
fig|33899.16.peg.7098 456 7.277228 putative membrane protein 
fig|33899.16.peg.3031 2235 6.983884 Limit dextrin alpha-1 C6-maltotetraose-
hydrolase 
fig|33899.16.peg.4315 1905 6.983884 Phage protein D 
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fig|33899.16.peg.8132 660 6.774179 Two-component transcriptional response 
regulator LuxR 
fig|33899.16.peg.7305 648 -6.04858 Transcriptional regulator AcrR family 
fig|33899.16.peg.7118 678 -6.28288 Integral membrane protein 
fig|33899.16.peg.1656 123 -6.92249 hypothetical protein 
fig|33899.16.peg.5554 1950 -7.0733 Methylcrotonyl-CoA carboxylase biotin-
containing subunit 
fig|33899.16.peg.3900 315 -7.20563 hypothetical protein 
fig|33899.16.peg.1659 201 -7.33455 hypothetical protein 
fig|33899.16.peg.3898 615 -7.59574 Transcriptional regulator Xre-family 
with cupin domain 
fig|33899.16.peg.979 1020 -7.91653 Putative oxidoreductase 
fig|33899.16.peg.1672 603 -8.26887 hypothetical protein 
fig|33899.16.peg.7304 1014 -10.3318 putative membrane protein 
 
v) Comparison between day 2 and 3 in WT 
Transcript ID length LogFC Gene product 
fig|33899.16.peg.7376 1569 10.59694 ABC transporter substrate-binding 
protein 
fig|33899.16.peg.4080 165 9.578356 ribosomal protein 
fig|33899.16.peg.7370 1257 9.289268 hypothetical protein 
fig|33899.16.peg.727 171 9.223787 ribosomal protein 
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fig|33899.16.peg.7372 1089 8.580242 Pyridoxal-5'-phosphate-dependent 
enzyme beta superfamily 
fig|33899.16.peg.728 1173 8.51201 Metal chaperone involved in Zn 
homeostasis 
fig|33899.16.peg.7371 831 8.414053 hypothetical protein 
fig|33899.16.peg.5861 981 7.937384 Zinc ABC transporter substrate-
binding protein ZnuA 
fig|33899.16.peg.7379 1566 7.755993 ABC transporter ATP-binding 
protein 
fig|33899.16.peg.7373 1032 7.609867 L-alanine-DL-glutamate epimerase 
fig|33899.16.peg.721 882 -3.72311 Putative oxidoreductase 
fig|33899.16.peg.710 999 -3.78439 Phytoene synthase  
fig|33899.16.peg.5163 879 -4.04775 Uncharacterized metal-dependent 
hydrolase YcfH 
fig|33899.16.peg.4714 741 -4.40582 Carbonic anhydrase beta class ( 
fig|33899.16.peg.5162 411 -4.52834 hypothetical protein 
fig|33899.16.peg.1863 243 -4.64917 Transcriptional regulator WhiB 
family; 
fig|33899.16.peg.799 396 -4.93157 UspA domain protein 
fig|33899.16.peg.796 969 -5.21315 Tripartite tricarboxylate transporter 
TctB family 




fig|33899.16.peg.6931 1212 -6.25786 hypothetical protein 
 
vi) Comparison between day 3 and 4 in WT 
Transcript ID start end length 
 
Gene product 
fig|33899.16.peg.1923 1791996 1793406 1410 
 
putative secreted glucosidase 
fig|33899.16.peg.205 177180 177399 219 
 
hypothetical protein 
fig|33899.16.peg.3573 3557437 3558379 942 
 
hypothetical protein 
fig|33899.16.peg.359 304144 305758 1614 
 
hypothetical protein 
fig|33899.16.peg.540 453379 453841 462 
 
hypothetical protein 
fig|33899.16.peg.6703 6948185 6948884 699 
 
Putative oxidoreductase 
fig|33899.16.peg.958 850978 851101 123 
 
hypothetical protein 
fig|33899.16.peg.7596 7880418 7880538 120 
 
hypothetical protein 
fig|33899.16.peg.2282 2173006 2174329 1323   hypothetical protein 
fig|33899.16.peg.2284 2174985 2175882 897   UDP-glucose 4-epimerase 
fig|33899.16.peg.1519 1409166 1409508 342 
 
Transcriptional regulator ArsR 
family 
fig|33899.16.peg.1518 1407439 1409170 1731 
 
Sulfate permease 
fig|33899.16.peg.798 689590 691090 1500 
 
Universal stress protein family 
fig|33899.16.peg.8049 8382171 8382678 507 
 
Flavodoxin 





fig|33899.16.peg.8089 8423869 8425426 1557 
 
Respiratory nitrate reductase beta 
chain 
fig|33899.16.peg.6550 6791217 6792891 1674 
 
Alpha-glucosidase AglA 
fig|33899.16.peg.6553 6795621 6796461 840 
 
Alpha-glucoside transport system 
permease protein AglG 
fig|33899.16.peg.6551 6792928 6794257 1329 
 
Alpha-glucosides-binding 
periplasmic protein AglE precursor 
fig|33899.16.peg.6552 6794263 6795625 1362 
 
ABC alpha-glucoside transporter 



















Aclacinomycin producing BGC detected by antiSMASH and the corresponding gene ID. 
Gene ID Locus tag Location Function 
  From To Length strand  
fig|33899.16.peg.2243 ctg1_2065 2133093 2133885 792 + Hypothetical protein/ 
DNA binding protein* 
fig|33899.16.peg.2244 ctg1_2066 2134121 2135501 1380 - Guanine deaminase  
fig|33899.16.peg.2245 ctg1_2067 2135668 2136595 927 - Urate oxidase  
fig|33899.16.peg.2246 ctg1_2068 2136599 2137004 405 - 5-hydroxyisourate 
hydrolase 





fig|33899.16.peg.2248 ctg1_2070 2137766 2138135 369 - DNA binding protein 
fig|33899.16.peg.2249 ctg1_2071 2138131 2138380 249 - Hypothetical protein 
fig|33899.16.peg.2250 ctg1_2072 2138675 2139497 822 + Hydroxypyruvate 
isomerase 
fig|33899.16.peg.2251 ctg1_2073 2139560 2140451 891 + 2-hydroxy-3-
oxopropionate reductase 
fig|33899.16.peg.2252 ctg1_2074 2141016 2141262 246 + Hypothetical protein 
fig|33899.16.peg.2253 ctg1_2075 2141418 2142069 651 + TIGR04222 domain-
containing membrane 
protein* 
fig|33899.16.peg.2254 ctg1_2076 2142218 2144099 1881 - Glyoxylate carboligase 
fig|33899.16.peg.2255 ctg1_2077 2144211 2145081 870 + Hypothetical protein 
fig|33899.16.peg.2256 ctg1_2078 2145117 2146725 1608 - Long-chain-fatty-acid--
CoA ligase 
fig|33899.16.peg.2257 ctg1_2079 2146721 2148392 1671 - Acetyle-CoA-synthetase 
fig|33899.16.peg.2258 ctg1_2080 2148515 2149358 843 + Transcriptional 
regulator 




fig|33899.16.peg.2260 ctg1_2082 2153155 2153947 792 + Trypsin-like 
protease/serine 
protease* 
fig|33899.16.peg.2261 ctg1_2083 2154084 2155203 1119 - Hypothetical protein/ 
DNA binding domain* 
fig|33899.16.peg.2262 ctg1_2084 2155344 2156199 855 - ABC-2 type transporter 
fig|33899.16.peg.2263 ctg1_2085 2156195 2157176 981 - ABC transporter ATP-
binding protein 
fig|33899.16.peg.2264 ctg1_2086 2157366 2157975 609 - Transcriptional 
regulator PadR family 
fig|33899.16.peg.2265 ctg1_2087 2158140 2158578 438 - AclR protein 
fig|33899.16.peg.2266 ctg1_2088 2158795 2159641 846 + Hypothetical protein/ 
NADPH-binding 
protein* 
fig|33899.16.peg.2267 ctg1_2089 2159655 2160387 732 + Hypothetical protein/ 
Methyltransferase* 
fig|33899.16.peg.2268 ctg1_2090 2160448 2162080 1632 - Putative oxidoreductase 
fig|33899.16.peg.2269 ctg1_2091 2162153 2162624 471 - Hypothetical protein/ 
Oxidoreductase* 
fig|33899.16.peg.2270 ctg1_2092 2162708 2163563 855 - Hypothetical protein/ 
Transcriptional 
regulator* 






2164022 2164147 125 - Hypothetical protein*+ 
fig|33899.16.peg.2273 ctg1_2094 2164231 2165092 861 + Methyltransferase* 
fig|33899.16.peg.2274 ctg1_2095 2165145 2166189 1044 - Modular polyketie 
synthase/ 
Acyltransferase* 
fig|33899.16.peg.2275 ctg1_2096 2166185 2167292 1107 - Acyl carrier protein 
synthase  
fig|33899.16.peg.2276 ctg1_2097 2167288 2167564 276 - Acyl carrier protein 
fig|33899.16.peg.2277 ctg1_2098 2167667 2168891 1224 - Polyketide chain length 
factor 
fig|33899.16.peg.2278 ctg1_2099 2168887 2170159 1272 - Beta-ketoacyl synthase 
101 
 
fig|33899.16.peg.2279 ctg1_2100 2170155 2170524 369 - Monooxygenase 
fig|33899.16.peg.2280 ctg1_2101 2170735 2171521 786 + Acetoacyl-CoA 
reductase. 
fig|33899.16.peg.2281 ctg1_2102 2171568 2172921 1353 + Hypothetical protein/ 
Cyclase* 
fig|33899.16.peg.2282 ctg1_2103 2173006 2174329 1323 + Hypothetical protein/ 
Glycosyltransferase* 
fig|33899.16.peg.2283 ctg1_2104 2174329 2174947 618 + Epimerase 
fig|33899.16.peg.2284 ctg1_2105 2174934 2175882 948 + NAD-dependent 
epimerase 
fig|33899.16.peg.2285 ctg1_2106 2175948 2177301 1353 + Hypothetical protein/ 
Dehydratase (AclN)* 
fig|33899.16.peg.2286 ctg1_2107 2177387 2178497 1110 - Aminotransferase 
fig|33899.16.peg.2287 ctg1_2108 2178719 2179595 876 + Putative glucose 
synthase (AclY)) 
fig|33899.16.peg.2288 ctg1_2109 2179607 2180324 717 - Methyletransferase 
fig|33899.16.peg.2289 ctg1_2110 2180385 2181165 780 - Putative cyclase 
fig|33899.16.peg.2290 ctg1_2111 2181375 2181810 435 + Cyclase/ Nuclear 
transport factor 
(AknV)* 
fig|33899.16.peg.2291 ctg1_2112 2181868 2182639 771 + Putative aklaviketone 
reductase 




fig|33899.16.peg.2293 ctg1_2114 2184070 2185402 1332 + Glycosyltransferase 
(AknS) 
fig|33899.16.peg.2294 ctg1_2115 2185389 2186361 972 + NAD-dependent 
epimerase/dehydratase 
fig|33899.16.peg.2295 ctg1_2116 2186469 2187459 990 - Oxidoreductase 
fig|33899.16.peg.2296 
 
2187468 2187587 119 - Hypothetical protein 
fig|33899.16.peg.2297 ctg1_2117 2187620 2188925 1305 + Putative 3-dehydratase 
fig|33899.16.peg.2298 ctg1_2118 2188938 2189757 819 - Transcriptional 
regulator 
fig|33899.16.peg.2299 ctg1_2119 2190024 2190204 180 + Hypothetical protein 
102 
 
fig|33899.16.peg.2300 ctg1_2120 2190200 2192468 2268 + AknN 
fig|33899.16.peg.2301 
 
2192465 2192641 176 
 
Hypothetical Protein 
fig|33899.16.peg.2302 ctg1_2121 2192703 2193963 1260 + Hypothetical protein/ 
Histidine kinase* 
fig|33899.16.peg.2303 ctg1_2122 2194035 2194641 606 - Response regulator 
transcription factor 
fig|33899.16.peg.2304 ctg1_2123 2194850 2195924 1074 - NAD kinase 
fig|33899.16.peg.2305 ctg1_2124 2196035 2197121 1086 - Hypothetical protein/ N-
acyltransferase* 
fig|33899.16.peg.2306 ctg1_2125 2197341 2197908 567 + Hypothetical protein/ 
ABATE domain-
containing protein* 
fig|33899.16.peg.2307 ctg1_2126 2197920 2198100 180 - Hypothetical protein 




2198997 2199203 206 + Hypothetical Protein 
fig|33899.16.peg.2310 ctg1_2128 2199252 2200704 1452 + Glycosylhydrolase  
fig|33899.16.peg.2311 ctg1_2129 2200836 2201637 801 + Polysaccharide 
deacetylase  
fig|33899.16.peg.2312 ctg1_2130 2201770 2202211 441 + Hypothetical protein/ 
Ligand binding 
domain* 
fig|33899.16.peg.2313 ctg1_2131 2202355 2203702 1347 + Hypothetical protein/ 
Lanthionine synthetase 
C family protein* 




Appendix 3:  
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CC - Day 4
109 
 
Appendix 4:  
Functional classifications of the mapped DEGs within the wild (a-d) and mutant (e-h) strain on 
different day intervals. Y-axis denotes the number of mapped DEGs into the corresponding 
pathway. W1. W2 . W3 and W4 refers to the corresponding sampling day of the WT strain. 
and M1. M2.M3 and M4 refers to the sampling day from the mutant strain. 
a) Amino acid metabolism: 
 




















































































































































































































































































































































































































































































































































































































































































d) Pathways involved to cellular processing (CP). genetic information processing (GIP) and 











































































































































































































































































































































































































































































































h) Pathways involved to cellular processing (CP). genetic information processing (GIP) and 

































































































































































































































































































DEGs mapped to aspartate, glutamate, and alanine metabolism (mapped DEGs are in yellow 
boxed with their corresponding EC (Enzyme code), EC: 6.3.4.4, EC: 6.3.5.4, EC: 2.6.1.16 










DEGs mapped to type II polyketide backbone pathway (mapped DEGs are boxed in yellow, 
and the pathways involved are in blue background). actI1; minimal PKS ketosynthase (KS/KS 
alpha), actI2; minimal PKS chain-length factor (CLF/KS beta), actI3; minimal PKS acyl carrier 










List of DEGs from the BGC responsible for producing spore pigment.  
 WT MT 
Gene ID W1-W2 W2-W3 W3-W4 M1-M2 M2-M3 M3-M4 
       
fig|33899.16.peg.7325 0.05 












































   
fig|33899.16.peg.7385 








Number of hypothetical proteins  in the different DEG lists.  
DEG list Total Total number of 
DEG 
% of hypothetical 
protein 
D1 234 891 26.26 
D2 459 1573 29.17 
D3 470 1638 28.69 
D4 413 1392 29.66 
W1-W2 251 915 27.43 
W2-W3 201 810 24.81 
W3-W4 103 353 29.17 
M1-M2 187 844 22.10 
M2-M3 42 145 28.96 











DEGs (from D2) mapped to glycolytic pathways are yellow box. The number represents their 
EC number. Embden-Meyerhof pathway showed in red color. DEGs within blue background 
were upregulated,  
 
